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Classical retrovirology had its birth in 1908 with Peyton Rous 
studying spontaneous sarcomas (tumors of the connective tissue) in 
chickens. He found that the sarcomas were transmissible and that the 
tumors showed greater virulence with each passage. He tested cell 
free filtrates for the presence of the etiological agent, and for the 
first time demonstrated that the entity involved in the transmissible 
sarcomas was a virus (Rous, 1911). This virus now bears his name, 
Rous sarcoma virus. 
Since Rous's famous discovery of a filterable entity that could 
induce tumor formation in infected chickens, countless other viruses 
have also been discovered that induced a variety of neoplastic growths 
in the infected host. With the new sophisticated techniques of today 
we have been able to probe the molecular events that occur during a 
retroviral infection in hopes of elucidating how these viruses not 
only induce their neoplastic growth but also the molecular events that 
• must occur to allow viral replication. At the time of this thesis, a 
major obstacle inhibiting detailed molecular studies of Rous sarcoma 
virus replication is the lack of adequate immortalized avian cell 
lines and expression vector systems. This thesis therefore is written 
in two parts. The first part addresses the block of RSV replication 
in mammalian cells. The idea was to devise a system to study 
retroviral assembly in immortalized cell lines. If we can elucidate 
the differences between the avian and murine retroviruses that allow 
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the murine viruses but not the avian viruses to replicate in mammalian 
cells, we might be able to better understand the molecular require-
ments for viral replication and assembly. 
In order to study this block to replication of avian 
retroviruses in mammalian cells, I chose to use the simian virus 40 
(SV40) as a vector to express the RSV gag gene (or the viral 
polyprotein Pr76 9a9 ) in mammalian cells. 
The second part of this thesis arose from a problem encountered 
while using the SV40 virus as an eukaryotic expression vector. The 
strategy for using this virus as an expression vector is quite simple. 
The sequence of choice to be expressed, gag, is cloned into the late 
region of the SV40 virus genome in place of the late genes. The ex-
pression of the foreign gene is then driven from the late SV40 
promoter. This recombinant vector can then be propagated with the 
help of a second SV40 virus that supplies the late gene products in 
trans. The problem was encountered while trying to propagate the 
recombinant vector. We were able to successfully express Pr76 but un-
able to passage any newly assembled recombinant virions to fresh 
monolayers. Instead of then abandoning the project, I chose to pursue 
the problem in hopes of finding the molecular block in SV40 replica-
tion. This is important since finding a sequence or protein that in-
hibits SV40 replication might prove to be a valuable tool for 
elucidating the mechanisms of viral replication. 
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CHAPTER I 
RETROVIRAL CHARACTERISTICS AND 
REPLICATIVE STRATEGIES 
General Characteristics 
Taxonomy of Retroviruses 
As with any new discovery of a living entity, the first scien-
tific observations performed are to clas~ify the organism into a 
genetic phylum or family. For a virus to be included in the viral 
family Retroviridae, it must meet the following criteria (Teich, 
1982): 
The nucleic acid must be composed of two identical molecules of 
positive-sense single-stranded RNA (60S-70S) joined at or near the 5' 
termini (Beemon et al., 1976; Bender et al., 1976). The molecule must 
also have a 5' "capped" structure (m7G5ppp5 'NmpNp) (Rose et al., 1976) 
and a polyadenylated 3' terminus (Bender et al., 1976) and two large 
repeated sequences (LTR) at each the 3' and 5' ends of the proviral 
DNA (Teich, 1984). The genome must have a tRNAtrp (or some other re-
lated tRNA) base-paired to the genome at a site approximately 100 
nucleotides from the 5' end (Bishop, 1978). This tRNA molecule is im-
portant in initiating proviral eDNA synthesis which is required for 
the replicative life cycle of all retroviruses. 
The virion must be composed of 60-70% protein. These proteins 
are all synthesized from three major coding sequences in the viral 
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RNA; gag, group associated antigens or structural proteins; pol, 
reverse transcriptase; and env, envelope glycoproteins. 
Another major criterion for classification of a virus into the 
retroviridae family is the physical structure of the virion which can 
be classified as either A•, B-, C-, or D-type (see below). 
Early electron micrographs of tumor cells depicted a structure 
budding from the surface membranes (Bernard et al., 1958). The bud-
ding virus was roughly spherical with a diameter of 90-100 nm. The 
inner electron dense core or nucleoid was surrounded by an outer 
lipid-containing membrane with projecting spikes (see Figure 2 for a 
schematic representation of such as a particle). 
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Since these early studies, microscopists have classified 
retroviruses ~nto four distinct categories according to their gross 
morphology and site of assembly. A-type particles are generally 60-90 
nm in diameter and have a doughnut-shaped internal spherical core. 
These intracellular particles are further classified into intracister-
nal and intra-cytoplasmic forms. The intracytoplasmic forms are 
thought to be immature type B particles or endogenous B- or D-type 
particles (see below). The destination of the intracisternal forms on 
the other hand is not known. 
B-type particles include the prototype mouse-mammary tumor virus 
(MMTV). These spherical particles are 125-130 nm in diameter with an 
electron dense core (75-80 nm diameter) located off center and en-
veloped by a lipid membrane with long projecting spikes. Fully 
formed nonenveloped particles can be seen in the cytoplasm of infected 
cells. 
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C-type particles are most common of the retroviruses with Rous 
sarcoma virus being the prototype virus. The most striking charac-
teristic of this group of viruses is the absence of intracellular par-
ticles. It is not until the budding process begins at the surface 
membrane that the particles become visible. After budding, the newly 
released immature virions are distinguished by their loosely-packed 
cores. Upon maturation, the cores condense into a crescent-shaped 
electron-dense structure similar to the core of B-type particles ex-
cept that the cores are centrally located within the outer envelope of 
the virion. 
D-type particles are quite different from A, B, and C-type par-
ticles. Mason-Pfizer monkey virus (MPMV) is the prototype virus of 
the group. Like the B-type particles, both intracellular and ex-
tracellular forms can be seen. • The major morphological difference be-
tween D.- and B- type particles is that D- type particles do not have a 
spherical core but instead have an elongated ring-like structure. 
Also, the outer-membrane spikes are shorter than those of the B- and 
C-type viruses. 
The Retroviridae can also be divided into three subfamilies 
based on their pathogenic properties. The oncovirinae, including all 
the oncogenic and related nononcogenic viruses, are classified accord-
ing to their host range and the type of neoplasm they induce (avian 
leukemia-leukosis virus, avian sarcoma virus, mouse mammary t~or 
virus etc.). The lentiviruses, or slow viruses, are cytopathic and 
induce a slow chronic degenerative disease (ie. visna virus). The 
third family of viruses are the spumavirinae, or foamy viruses. These 




As mentioned earlier, the packaged viral RNA is modified with 
both 5' cap structures and poly (A) tails (Rose et al., 1976; and 
Bender er al., 1876). Therefore, the viral RNA can also serve as a 
functional mRNA (see below). Because the most detailed information 
about the genomic structure has been worked out using the Rous sarcoma 
and avian leukosis viruses (RSV and ALV respectively) and the murine 
leukemia virus (MLV), this discussion will be limited to these 
prototype viruses. 
Figure 1 shows the genomic structure of three replication profi-
cient retroviruses. RSV is the only known retrovirus to contain all 
the sequences and genes needed for replication (two LTRs, gag, pol, 
env, and etc.) and a viral oncogene, src. Other retroviruses are 
known to carry viral or cellular oncogenes, but they do so at the ex-
pense of an essential region. These viruses are "replication defi-
cient" and can only be propagated with a helper virus supplying the 
missing factors in trans. 
The 5' regulatory regions are required for transcription initai-
tion and eDNA synthesis. The "R" region is a short repeated sequences 
(20-80 nucleotides) at both ends of the genome that are apparently re-
quired for replication of the viral RNA. The "Us" is a 5' unique 
sequence (approx. 100 nucleotides) that separate the R region and the 
tRNA binding site. This tRNA binding is the "PB-" region. The tRNA 
serves as the primer for DNA synthesis via reverse transcriptase. The 
sequence is complementary to the 3' termini (16-19 nucleotides) of 
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Figure 1. Genomic map of three different retroviruses. 
the tRNA trp molecule. "L" is a long untranslated region (approx. 250 
nucleotides) which contains the sequences required for viral RNA 
(vRNA) packaging as well as those sequences needed for efficient 
transcriptional initiation. 
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The translated regions or structural genes are always in the or-
der gag, pol, env, (and src in the case of RSV). The gag gene 
(approx. 2000 nucleotides) codes for the structural proteins as-
sociated with the internal core. The products of the gag coding 
region are also responsible for the group-specific antigens that were 
once used to distinguish the different groups of retroviruses. The 
product of the gag coding region is a precursor polypeptide that must 
undergo proteolytic processing to generate the structural proteins. 
The pol coding region (approx. 3000 nucleotides) encoding the RNA-
dependent DNA polymerase or reverse transcriptase. The active enzyme 
(either one or two peptides depending on the particular virus) is a 
processed product from a precursor polypeptide. This processing event 
is required to give the active polymerase along with an indispensable 
endonuclease and RNAse H activity. Figure 2 shows the location of 
reverse transcriptase in the virion. Even though this diagram depicts 
only two reverse transcriptase molecules associated with the virion, 
it is not meant to imply there are only two. In fact there are over 
50 copies present per virion in MMTV (Panet et., 1975a). The env 
coding region (approx. 2000 nucleotides) codes for the surface 
glycoproteins. These glycoproteins, or spikes, are required for viral 
attachment to host-specific cell surface receptors and confer subgroup 
antigenicity. The product is also synthesized as a polyprotein 
precursor and at least one of the the processed proteins is glycosy-
lated before it is incorporated into the viral envelope. The src 
coding region (approx. 2000 nucleotides) codes for the protein kinase 
responsible for the rapid transformation of infected cells. The 60 
kilodalton (kDa) phosphoprotein is also translated from a spliced 
rnRNA. RSV is the only replication profecient retrovirus to carry a 
viral oncogene. 
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The 3' regulatory regions are primarily required for eDNA syn-
thesis and addition of the poly(A) tail. The "PB+" region is the 
counter part to PB-. The function of the site is not known but it is 
probably important since this sequence is highly conserved among the 
members of the retroviral family. "U3" is a unique region near the 3' 
end between PB+ and R. It is known that u3 contains the strong enhan-
cers required for initiation of transcription (Coffin, 1984). 
Architecture of the Virion 
All retroviruses have a similar physical structure. Both copies 
of the viral RNA are coated by viral specific proteins. This 
nucleoprotein complex along with 20-70 copies of reverse transcriptase 
(Panet et al., 1975; Dickson et al., 1984) is packaged into internal 
cores. These cores are surrounded by an outer membrane with protrud-
ing viral glycoproteins (see Fig. 2). The outer membrane is derived 
from the host cell during the process of viral budding. Since most of 
the information about the physical structure of retroviruses has been 
obtained through studies using RSV, the following discussion will be 
limited to RSV. 
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The outer membrane of RSV is derived from the host cellular 
membrane and is studded with numerous glycoprotein projections con-
sisting of the two structural peptides encoded by the env gene. The 
membrane anchoring protein, gp37 is covalently attached via disulfide 
bonds to the larger glycoprotein, gp85. This larger peptide is 
responsible for recognizing the host cell-surface receptors (Varmus 
and Swanstrom, 1982, and Weiss, 1982). 
The amino-terminal gag peptide, p19, is found associated with 
the viral envelope along with plS and the newly identified plO. The 
major capsid protein is p27. Within the capsid are the viral RNA 




Figure 2. Schematic representation of the structural organiza-
tion of a type-C retrovirus (Rous sarcoma virus). The location of the 
different viral proteins is indicated with arrows. Question mark in-
dicat~that the precise location between the core and envelope of 
viral proteins, plO, pl9, and plS is not known. R.T. is reverse 
transcriptase. 
Replicative Cycle 
The replicative cycles of retroviruses are quite complex yet 
very similar. Therefore, the following discussion will again be 
limited to RSV unless otherwise indicated. 
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As discussed by Varmus and Swanstrom (1982), the first step of 
infection is the entry of the virus into the host cell. This requires 
attachment of the virus to the host outer-membrane to allow adsorption 
of the virus possibly by an endocytotic event. It has been 
hypothesized that the capsid then makes its way to the nucleus by some 
unidentified mechanism while making a eDNA copy of the viral RNA 
(Varmus et al., 1974; Aboud et al., 1979; Jolicoeur and Baltimore, 
1876a and 1976b; and Krontinis et al., 1973). Once the capsid has 
reached the nucleus, the eDNA is released there thus allowing the DNA 
to become integrated into the host chromosome. The provirus can then 
be passed through the germ line or undergo a productive infection 
using th~ host RNA and protein synthesizing machinery to produce 
progeny virus. After all viral RNAs and proteins have been syn-
thesized, the virus is assembled into infectious progeny particles 
(Varmus and Swanstrom, 1982). 
Entry of the Virus 
The first step toward a productive infection is adsorption of 
the virus to the host cell via viral glycoproteins and specific host-
cell surface receptors (Varmus and Swanstrom, 1982; Weiss, 1982). 
Most nonpermissive cells can block infection at this step (Duff and 
Vogt, 1969). Other nonpermissive cells allow viral attachment and 
penetration but block viral replication at other stages of the viral 
life cycle (Weiss, 1982). 
The steps required for transport of the viral nucleic acid from 
the cell surface to the nucleus are not clear. There is very little 
information about the structure of the virion after penetration and 
the onset of eDNA synthesis. Varmus et al. (1974) suggest that viral 
DNA synthesis commences in the cytoplasm 3 hours after infection. 
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Since deoxyribonucleotide triphosphate. (dNTP) concentrations are low 
in the cytoplasm, one would expect DNA synthesis to occur at a slow 
rate. Their data shows that 32P-labeled dNTPs begin to be incorporated 
into viral DNA in the cytoplasm after 3 hours and does not arrive in 
nucleus till 10 hours post-infection. This data along with the fact 
that viral DNA can be made in enucleated cells is strong evidence that 
DNA synthesis does indeed occur in the cytoplasm. Indirect evidence 
has also accumulated that suggests that uncoating of the core may 
begin in the cytoplasm as early as two hours after infection when as-
sayed by reverse transcriptase (R.T.) activity in pelleted cell 
lysates (Aboud et al., 1979). They suggest that in these experiments, 
uncoating of the viral particles in the cytoplasm of the infected 
cells can be followed by the disappearance of R.T. activity. 
Since the rate of viral DNA synthesis is so slow (30 nucleotides 
per minute), the DNA-RNA hybrid molecule must somehow be protected 
from nucleases to allow for a full length genomic DNA molecule to be 
made (Varmus et al., 1978). One explanation is that after viral at-
tachment, the core is released into the cytoplasm. Here the core not 
only protects the viral RNA but also harbors reverse transcriptase in 
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its active form. Once dNTPs appear in the core, reverse transcription 
begins. It would seem plausible that the core also serves as a 
shuttle for the genetic material from the cytoplasmic membrane to the 
nucleus. In fact many inestigators have shown that certain mouse 
cells can restrict the appearance of MLV eDNA in the nucleus by the 
action of the Fv-1 allele (Jolicoeur and Baltimore, 1976a and 1976b; 
Sveda and Soeiro, 1976; Rassart and Jolicoeur, 1980 and Krontinis, 
Soeiro, and Feilds, 1973: Boone et al., 1983; and Des Groseillers and 
Jolicoeur, 1983). It was further shown by nucleotide sequencing of 
revertant viruses, which had overcome the effects of the Fv-1 allele, 
that the only changes that had occured were single amino acid changes 
at positions 109 and 159 in p30 (Ou et al., 1983). These results sug-
gest that the capsid protein is important in shuttling the genetic in-
formation to the nucleus. 
Viral DNA Synthesis 
Once all the appropriate factors for eDNA synthesis have accumu-
lated in the core, reverse transcription begins. The first molecule 
needed by reverse transcriptase besides the RNA template is tRNAtrp. 
Biochemical studies have shown that the tRNAtrp serves as the primer 
for reverse transcriptase by annealing the 3' end of the tRNA molecule 
to the PB- region on the viral RNA just down stream from the Us region. 
(Cordell et al., 1976 and 1978). DNA synthesis begins at the Us region 
and proceeds through the Us and R regions to the 5' terminus creating a 
"strong-stop" DNA-RNA molecule. The RNAse H activity of reverse 
transcriptase is then thought to remove the 5' R region of the viral 
RNA leaving a "sticky" R region overhang (Varmus, 1977; Myers et al., 
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1980; and Olsen and Watson, 1980). The overhang can now base pair 
with the 3' R region of the second viral RNA or to the original 
template RNA. In any case, reverse transcriptase can use the strong-
stop DNA as a primer for continued DNA synthesis through the 3' R and 
U3 regions then through the structural genes. The transcriptase again 
reads through the u5 and R creating another genomic length strong-stop 
DNA. RNAse H again digests away one strand of the 5' R allowing the 
5' R overhang to base pair with the original strand's 3' R. This al-
lows for 3' R and u3 again to be transcribed into the new eDNA. RNAse 
H then digests the RNA from the DNA-RNA hybrid molecule (for review 
see Varmus and Swantrom, 1982). The question how the second plus 
sensed DNA is synthesized still remains a mystery (Varmus and 
Swanstrom, 1984). It has been suggested that RNAse H might cleave the 
viral RNA into fragments that can be used as primers by the host DNA 
polymerase for the second DNA strand synthesis (Leis et al., 1973). 
In any case, the resulting complementary DNA (eDNA) has the following 
genomic structure depicted in Figure 3. 
After the double-stranded linear eDNA molecule has been made, it 
circularizes to form a circle junction between the two LTRs. Whether 
or not this event actually occurs inside the viral core or the nucleus 
has not been determined (Bishop, 1978). Once the circular DNA trans-
verses the nuclear membrane, it may integrate into the host chromosome 
(Varmus et al., 1973b and 1976; Khoury and Hanafusul, 1976; and Varmus 
and Swanstrom, 1984) by means not fully understood. It seems that the 
two LTRs are essential along with the endonuclease activity of reverse 
transcriptase for correct integration (Panganiban and Temin, 1984; 
Donehover and Varmus, 1984). The sites for integration seem to be 
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Figure 3. Rous sarcoma virus proviral structure. The 
splice donor (s.d.), and splice acceptor (s.a.), required to 
make the different mRNAs for each gene are listed. The gag 
and pol genes are transcribed as a single message. 
some what random (Hughes et al., 1978). However, whether or not the 
integrated provirus can induce tumorogenesis or effeciently express 
its own gene products semms to be, in part, determined by the site of 
integration (Varmus and Swanstrom, 1984). Many investigators have 
also tried to implicate DNA methylation, chromatin configuration, and 
chromosomal position with this efficiency (Groffer et al., 1983; 
Groudine et al., 1981; Chriswell et al., 1982; Jaenisch et al., 1983; 
and Katz et al., 1983). 
Retroviral Expression 
After the provirus has integrated, viral RNA can be synthesized. 
However, there is no clear evidence to suggest that integration is an 
absolute requirement for transcription of viral RNA. 
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Synthesis of Viral mRNA. 
Viral mRNA synthesis is not only dependent upon the presence of 
host RNA polymerase II but upon also functional promoters and enhan-
cers. Numerous studies on retroviral promoters have mapped the 
promoters to the LTRs and more specifically to u3 . Sequence and 
genetic analysis has confirmed the presence of a conserved "TATA" box 
24-30 b.p. before the "cap" site in RSV (Yamamoto et al., 1980; 
Ostrowski et al., 1981; and Fuhrman et al., 1981). Deletion of this 
TATA sequence dramatically reduces transcriptional initiation both in 
vivo and in vitro (Mitsialis et al., 1983b). Mitsialis et al. (1983a) 
has demonstrated the importance of the enhancer elements by 
demonstrating that the removal of the probable enhancer sequence 
(position -114 to -299) markedly decreases but not abolishes the 
ability of the promoter to initiate transcription in vivo. This 
region also is dispensible for transcription initiation in vitro. 
Luciw (1983) determined that the enhancer element probably lies at 
least 140 b.p. upstream from the transcription initiation site (Varmus 
and Swanstrom, 1984). Arrigo et al. (1987) have also identified 
another enhancer-like sequence within the plO coding region. This 
enhancer is unique in that it seems to have orientation polarity. The 
biological significance of this enhancer is not known since the enhan-
cer elements that drive transcription of the viral RNAs are located in 
the LTRs. 
Examination of the mature viral specific mRNAs found in the 
cytoplasm of RSV infected permissive cells reveals three major classes 
of mRNA. The largest species has a sedimentation coefficient of 38S 
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and is made up of approximately 10,000 nucleotides with a molecular 
weight of 31.3 x 106 . The second largest species, 28S, has a molecular 
weight of 1.8 x 106 (5400 nucleotides) while the smallest, 21S, has a 
molecular weight of 1.2 x 106 and is made up of approximately 3600 
nucleotides (Bishop, 1978). Both Weiss et al. (1977) and Howard et 
al. (1977) used stringent DNA-RNA hybridization techniques to reveal 
the probable function of each of the three classes of RNA. They 
probed with several cDNAs that corresponded to either; (a) the 3' ter-
minus, (b) specific internal sequences (gag, pol, env, or src), and 
(c) the 5' terminus. They found that all three species annealed with 
the 3' terminal probe (see Fig. 4). The largest 38S species annealed 
with all the probes suggesting that this RNA was a full-length genomic 
copy. The 28S RNA annealed with the 5', env, src, and 3' probes. The 
21S RNA had similar annealing patterns but did not anneal to the env 
probe. These results strongly suggest that all three species of viral 
RNA must origipate at the 5' region of the viral genome and that some 
kind of RNA splicing event must take place within the genomic length 
rnRNA to give rise to the RNA species that can translate the 5' ter-
minal sequence. These observations are consistent with the fact that 
eukaryotic ribosomes can only translate the 5'terminal open-reading 
frame given the correct ribosome binding sites and correct initiation 
codon. Direct sequence analysis of genomic eDNA has revealed the cor-
rect consensus sequences required for RNA splicing (Swartz et al., 
1983). The splice donor and splice acceptor sites are also consistent 
with the size and sequence. of the smaller classes of rnRNAs. The only 
viral sequence that is expressed without being positioned at the 5' 
end of a subgenomic viral RNA is the pol coding sequence. The 
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Figure 4. The major spliced mRNAs from Rous sarcoma 
virus and murine leukemia virus. The wavy lines at the 5' 
termini represent the common nucleotide sequences present in 
the 28S or the 35S transcript are found in the smaller 
transcripts ~s a result of splicing (see Fig. 2 for the ac-
tual splice donor and acceptor sites). A0 represents the 
poly A tail and CAP represents the 5' capped structures which 
are present on each transcript. 
Structural examination of many retroviral RNAs have revealed 
that all the genomic and subgenomic RNAs have methylated 5' caps as 
well as 3' poly-A tails (Bishop, 1978). DNA sequence analysis has 
revealed a sequence that is commonly referred to as a polyadenylation 
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signal (AAUAAA) 10-20 nucleotides 5' of the poly-A tail. As described 
by Varmus and Swanstrom (1982), in vitro translation studies of each 
of the three RNA classes has confirmed the predicted products. The 
38S RNA can probably be used for either progeny viral RNA or mRNA. 
The decision whether or not the RNA is to be used for mRNA is not un-
derstood. This 38S mRNA is translated into two large polypeptides in 
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RSV. The larger peptide has a molecular weight of 180 kDa and is 
referred to as Pr 180989 ·~l. The smaller peptide has a molecular 
weight of 76 kDa and is referred to as Pr76989 . The prefix "Pr" refers 
to the "precursor" polypeptide. As will be described later, both of 
these large polypeptides will undergo proteolytic processing to form 
the active viral proteins. The 28S RNA serves as the message for 
Pr90env and is usually found associated with polyribosomes bo.und to the 
rough endoplasmic reticulum. The samller 21S RNA gives rise to pp60src 
(or phosphprotein). Prl80gag·pol, Pr 76989 , and pp60src are found as-
sociated with free cytoplasmic polyribosomes. 
Other type-C retrovirus transcription strategies examined to 
date are generally the same. Other retroviruses such as HIV and HTLV 
I have very different transription stratagies in order to regulate 
viral gene expression (Weiss, 1985) and will not be described here. 
Murine leukemia virus (MLV) infected permissive cells transcribe two 
major RNA classes with sedimentation coefficients of 35S and 22S-24S. 
The 22S-24S RNA is mainly found associated with membrane-bound 
polyribosomes and codes for a protein precursor for the env 
glycoprotein. The larger 35S RNA is found associated with free 
polyribosomes and has been shown to code for the precursor products of 
gag and pol. It has also been shown that the 5' termini has sequence 
homology with the 5' end of gag suggesting a splicing event occurs to 
give rise to the 22S-24S RNA. 
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Synthesis of Viral Proteins 
As mentioned earlier, retroviruses not only require the RNA 
splicing capabilities of their host for expressing a relatively large 
array of virus-specific proteins from a limited information source, 
but, they also process large polyprotein precursors into smaller ac-
tive proteins. By using both of these strategies, simple retroviruses 
can ultimately produce 8-9 or proteins from their open reading frames. 
Other retroviruses such as the human retroviruses HTLV I, HTLV II, and 
HIV, the feline leukemia virus (FeLV), and Bovine leukemia virus 
(BLV), may produce many more virus-specific proteins from alternative 
coding sequences generated from multiple splicing events, But the 
theme for expressing the·major structural proteins from two or three 
large transcripts is generally the same. Therefore the following 
review of retroviral translational products will be limited to the 
more simple prototype viruses; RSV and MLV both C-type particles, and 
MMTV, a B-type particle. 
Synthesis of the Group-associated AntiGens (gag). The primary 
translated product of the full genomic-length 38S mRNA is a poly-
protein precursor (Pr76 in RSV, Pr65 in MLV, and Pr77 in MMTV). This 
precursor protein undergoes proteolytic cleavage into four or five 
polypeptides that are associated with the viral core. The final 
cleaved gag products are listed in Table 1. Of the three retroviruses 
listed, RSV is the only virus which synthesis its protease as part of 
the gag polyprotein precursor. This protease is found as part of the 
gag-pol fusion peptide in the murine viruses (Dickson et al, 1985). 
TABLE I 
AVIAN AND MURINE VIRION PROTEINS 
AND THEIR POLYPROTEIN PRECUSORS 
Virus Precursor Lipid-binding Genome-binding Capsid Nucleoprotein Protease 
Polyprotein Protein Protein Protein 
RSV Pr76 pl9 *plO p27 pl2 plS 
MLV Pr65 plS ppl2 p30 plO -- -** 
MMTV Pr77 plO pp21 p28 pl4 -- -** 
* p10 has only recently been identified and its function has not yet been elucidated (Dickson et al, 1982). 




In RSV, pl9 is located at the amino-terminus of Pr76. In its 
cleaved form pl9 is found associated with the viral envelope. It has 
also been reported that pl9 exists in both a phosphorylated or un-
modified form. It is not clear yet what the important functions of 
the phosphorylations are (Erikson et al., 1977). 
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It was at one time suggested that pl9 also had a high 
specificity for binding to viral RNA (Darlix and Spahr, 1982). It was 
thought since pl9 associated with both the viral RNA and viral en-
velope, that pl9 played some important role in RNA packaging and RNA 
splicing (Sen and Todaro, 1977; Leis et al., 1978, 1980). It has 
since been determined that pl2 and not pl9 that binds to RSV RNA 
(Meric et al., 1984). 
Schlesinger et al. (1976) and Montelaro et al. (1978) propose 
that the cytoplasmic tail of gp37 associates with pl9 in some manner 
in order to align Pr76 in the right orientation at the site of bud-
ding. In fact, Gebhardt et al. (1984) were able to chemically cross-
link pl9 and gp37 with dithiobispropionimidate (DTBP). The equivalent 
proteins in MLV, FeLV (feline leukemia virus), BLV (Bovine leukemia 
virus), and the D-type MPMV, are also found associated with the viral 
envelope. There is a major difference however between the mammalian 
and avian lipid-binding proteins. In the mammalian system, this 
protein is myristylated near the amino-terminus (Henderson et al., 
1983; Dickson et al., 1982). This modification must be important to 
the mammalian system since it is conserved among the mammalian 
retroviruses. The avian retroviral proteins on the other hand are not 
myristylated but rather acylated with an acetyl group (Palmer et al., 
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1978). It has been proposed that these post-translational modifica-
tions might be important in targeting the precursor polypeptide to the 
site of viral assembly (J. Wills, pers. comm.). 
The second protein of Pr76, carboxy proximal to pl9, is plO. 
This peptide has only recently been identified (Pepinski and Vogt, 
1983 and Hunter et al., 1983). It has been shown that this protein is 
soluble in methanol and trichloroacetic acid, labels poorly with the 
commonly used radioactive amino acids, and migrates with peculiar 
mobilities in SDS-gels. Therefore this protein escaped detection in 
SDS-polyacrylamide gels. The presence of the plO coding sequence in 
gag was identified after DNA sequence analysis (Schwartz et al., 
1983). This protein was later found between the viral envelope and the 
nucleocapsid and determined to comprise 7% of the total protein of the 
virion (Pepinsky and Vogt, 1983). The function of plO is not known 
but amino acid sequence analysis exhibits a high degree of sim~larity 
with pl2 of MLV. 
The major capsid protein in RSV is p27. Biochemical data has 
shown that p27 can form multimers when chemically cross-linked with 
dimethyl suberimidate (DMS) or dithiobispropionimidate (DTBP) suggest-
ing that the monomers are in close association with one another to 
possibly for the viral core (Pepinsky et al., 1980). Burnette et al. 
(1976) demonstrated that the MLV equivalent, p30, can self associate 
in solution. These observations are consistent with the idea that 
these proteins can associate with one another to form the viral core. 
The major polypeptide of the ribonucleoprotein complex is pl2 in 
RSV, plO in MLV, and pl4 in MMTV (Meric et al., 1984; Bolognesi et 
al., 1973; Schulein et al., 1978; Nermut et al., 1972; Fleissner and 
22 
Tress, 1973; Arthur et al., 1978b; Nusse et al., 1980; and Dickson et 
al., 1982). These proteins are highly basic and do not seem to have a 
higher affinity for single-stranded RNA over double-stranded RNA 
(Dickson et al., 1982). 
This RNA-binding protein is the carboxy terminal protein of the 
precursor polypeptide in the murine systems. The avian retroviruses 
differ in that there is one more peptide carboxy-proximal to the RNA-
binding protein. This protein is known as pl5. By a series of in 
vivo and in vitro techniques, Vogt et al. (1979) was able to 
demonstrate that pl5 was a protease. They also demonstrated that this 
protease specifically cleaved Pr76 into the five structural proteins 
seen in the mature virion. Von Der Helm (1980) also demonstrated that 
pl5 had protease activity by showing that Pr76 could be correctly 
processed in nonpermissive cell lines (rat TWERC and hampster RBH 
cells) by microinjecting purified pl5. The location of pl5 in the 
virion was determined by Pepinsky et al. (1980). They were able to 
show by chemical crosslinking that pl5 is located between the 
nucleocapsid and the viral envelope. 
No equivalent protease is found in the murine gag polypeptide. 
This activity however is found as part of the gag-pol fusion 
polyprotein and is encoded by the pol sequence. This protease has 
similar specificity for cleavage of the Pr659a9 polypeptide in MLV 
(Levin et al., 1984; Dickson et al., 1984). 
Synthesis of Reverse Transcriptase. In RSV virions, active 
reverse transcriptase is isolated as a two-subunit enzyme: the alpha 
subunit has a molecular weight of 58 kDa while the beta subunit has a 
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molecular weight of 92 kDa (Dickson et al., 1982). Both subunits seem 
to have the RNA-dependent DNA polymerase activity as well as the in-
dispensable RNAse H activity (Verma, 1977). The alpha subunit has 
been demonstrated by numerous investigators to be derived by 
proteolytic processing of the beta subunit in the maturing virion 
(Dickson et al., 1982). It seems that the alpha subunit is derived 
from the carboxy-terminus of the beta subunit. The endonuclease ac-
tivity which is required for integration of the eDNA into the host 
genome, is found at the carboxy terminus of reverse transcriptase. 
This endonuclease, p32, cleaves the circular double-stranded eDNA 
prior to the integration step (Varmus and Swanstrom, 1982). It seems 
reasonable to envision that this endonuclease is also impor~ant in the 
actual process of integration. Dickson et al., (1982) suggest that 
two beta subunits complex together and that one of these is a precur-
sor to the alpha and p32 subunits in the mature virion. Fractionation 
studies on purified virions show that the active transcriptase co-
purifies with the viral RNA (Stromberg et al., 1974). Panet et al. 
(1975b) demonstated that reverse transcriptase specifically binds the 
tRNAtrp primer and therefore might possibly be tightly associated with 
the viral RNA. It has also been shown that the reverse transcriptase 
selects the correct tRNA and might possibly be responsible, although 
indirectly, for the correct packaging of viral RNA (Levin and Seidman, 
1979; Sawyer and Hanafusa, 1979; Peters and Hu, 1980, Dickson et al., 
1082). It is also interesting to note that the sequence required for 
packaging of the viral RNA (L region) is located directly adjacent to 
the tRNA binding site (PB-) in RSV. 
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Reverse transcriptase is first synthesized as part of a gag-pol 
fusion protein (ie., Prl80gag-~l in RSV) in all retroviruses examined 
to date. The first direct evidence that Prl80 was the precursor 
product to reverse transcriptase was obtained by immunoprecipitation 
experiments using anti-reverse transcriptase antiserum (Oppermann et 
al., 1977; Hayman, 1978; and Retteniner et al., 1979). These experi-
ments also demonstrated that gag specific amino acid domains were 
present by using antisera raised against purified gag proteins. 
However, the levels of Prl80gag"pol in infected cells are 20 to 50 fold 
lower then Pr769a9 . This is not surprising considering the possible 
mechanism by which the gag-pol fusion protein is made (Stromberg et 
al., 1974; Panet et al.,l975a). Schwartz et al. (1983) identified, by 
sequence analysis, two open reading frames, one coding for Pr76 and a 
second coding for the presumptive reverse transcriptase. The sequence 
analysis actually generated more questio~s than it answered. A 
perplexing question was inspired when it was demonstrated that the two 
coding regions were actually in different reading frames with pol 
being in the -1 reading frame with respect to gag. This data also 
showed that the two reading frames overlapped by 58 nucleotides with 
respect to the gag amber codon. However, according to the amino acid 
sequences of the mature reverse transcriptase and Pr76, the two read-
ing frames should be separated by 20 nucleotides on the RNA. The 
first and most obvious explanation was that the precursor peptide was 
generated from a spliced RNA that had the intervening sequences 
removed. Further detailed study of the nucleotide sequence did not 
reveal the splice donor and splice acceptor consensus sequences (see 
Fig. 5). Therefore, it was suggested that there must be some minor 
C A T C 
AGGT AGT-----------/1---------- N AGG 
A G C>11 T 
Figure 5. Consensus sequence for known splice donor and 
splice acceptor sites. The invariant GT and AG are indicated 
in italics (Mount, 1982). 
sequence that is involved in the RNA splicing activites. 
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Because of the results presented by Jacks and Varmus (1985), the 
most excepted idea is that there is an occasional ribosomal frameshift 
during translation that allows the ribosome to fall back into the -1 
reading frame and begin translation of reverse transcriptase. They 
demonstrated with well defined in vitro transcription and translation 
systems that the gag-pol fusion protein in RSV was translated via 
ribosomal frameshifting events. By deletion analysis, they identified 
a stretch of nucleotides near the 3' end of the gag coding sequence 
that was important in this event (see Fig. 6). 
Jacks et al., (1987) also showed that MMTV translated its gag-








Figure 6. Diagram of the 58 nucleotide overlap between the 
two open reading frames for the gag and pol proteins and the 
amino acid sequence encoded by the 3' end of gag (upper amino 
acid sequence) and the 5' end of pol (lower amino acid 
sequence). The underlined nucleotides indicate were the 
frameshifting signals are located. 
different in that it requires two ribosomal frameshifts to generate 
the fusion protein. Detailed sequence analysis has identified a 
potentially important consensus sequence, A AAA AAC, that is found in 
MMTV, BLV, and HTLV-2. They go on to suggest that the sequence U UUA 
near the amber codon of gag in RSV is the probable frameshifting sig-
nal. They also propose that the context in which this sequence lies 
is very important in that a stem-loop structure must be present down-
stream in order to stimulate the ribosomal frameshift. The idea of a 
ribosomal frameshift is further supported by Moore et al., (1987). 
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Synthesis of the Viral Glycoproteins. The product of the 
spliced 28S mRNA in RSV is the precursor polypeptide, Pr95env (see 
Table 1 for analogous proteins in MLV and MMTV). Unlike Pr769a9 and 
Prl80gag·pol, Pr95env is not synthesized on free polyribosomes but rather 
on the rough endoplasmic reticulum (RER). Pr95env is similar to many 
other host polypeptides synthesized on the RER in that these peptides 
are modified by glycosylation and other post-translational modifica-
tions. Most of these glycosylated proteins are destined for the cell 
surface and common among them are the presence of a very hydophobic 
stretch of amino acids at the amino terminal end of the growing pep-
tide chain. This hydrophobic region is thought to interact with the 
membrane of the RER. 
It has been hypothesized that the amino terminal sequence of 
Pr95 harbors a recognition signal for a host "signal recognition par-
ticle (or SRP). This SRP not only arrests protein synthesis in the 
cell cytoplasm (Lipp et al., 1987), but it is also recognized by SRP 
binding proteins on the endoplasmic reticulum. Also present on the 
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RER are ribosome.binding proteins. Through a complicated series of 
events not fully understood, the ribosome becomes bound to the RER and 
the leader peptide is translocated across the membrane into the cis-
terna of the ER. Present in the cisterna are signal peptidases which 
cleave the signal peptide and recycles the host SRPs allowing protein 
synthesis to ensue. Glycosylation of the growing peptide results from 
specific signals on the viral peptide and host glycosylation enzymes 
(Sefton, 1976; Dickson et al, 1982). For a more intensive review see 
Hirschberg and Snider (1987). 
Both in vitro translation and microinjection studies have shown 
that the 28S mRNA specifically encodes the retroviral env product. In 
vitro translation systems using purified 28S mRNA result in a polypep-
tide of approximately 70 kDa (Pawson et al., 1977). In vivo studies 
using the glycosylation inhibitor tunicamycin also result in an un-
glycosylated protein of approximately 70 kDa (Shapiro et al., 1976; 
Moelling et al., 1977; Bishop, 1978). Stacey et al. (1977) also 
demonstrated that the.28S mRNA encodes the viral gylcoprotein by 
microinjecting the 28S mRNA into cells infected with an RSV env dele-
tion mutant and showing that the RNA could complement the defective 
virus. 
Addition of the high manose oligosaccharide takes place as the 
nascent polypeptide translocates into the endoplasmic reticulum and 
translation continues. After the high mannose precursor is 
transported to the Golgi apparatus where the complex oligosaccharides 
are added, Pr95env is cleaved by unknown host proteases to generated 
gp85 and gp37 (Wills et al., 1984). The env precursor in MLV Pr90env, 
is similarly processed into gp70 and plSE and Pr73env in MMTV into gp52 
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and gp36. DNA sequence analysis has predicted the presence of a very 
hydrophobic region near the carboxy terminus of gp37. This 
hydrophobic stretch of amino acids serves as a membrane anchoring 
domain. Thus, a short peptide tail projects into the cytoplasm of the 
host cell. The function of this tail will be discussed later. The 
larger processed glycoprotein (gp85) makes up the body of the surface 
spikes on the mature virion and is covalently linked to the membrane 
anchoring protein by disulfide bonds (see Fig. 2). In both the avian 
and murine retroviruses, the smaller peptide can be removed after 
treatment with reducing agents such as beta-mercaptoethanol (Leamnson 
and Halpern, 1976; Dickson et al., 1982). The spike complex in its 
mature form is capable of recognizing and attaching to specific host 
surface receptors not yet identified (Dickson et al., 1982 and 1984). 
RSV Oncogenes and Other Phosphorylated Proteins. The third 
major message found only in RSV (as described earlier) codes for a 
phosphoprotein, pp60src. This protein, termed vsrc (viral sarcoma), 
has also been called the transforming protein because of its involve-
ment in transforming infected cells into a neoplastic state. Since 
this protein is not found in the RSV virion nor involved in retrovirus 
replication, assembly, or maturation, it will not be discussed in fur-
ther detail (for a detailed review, see J.M. Bishop and H. Varrnus, 
1982 and 1984). 
Two other viral proteins are also phosphorylated. It is 
generally believed that this type of post-translational modification 
is important in biological regulation. Both pl9 of RSV and pl2 of MLV 
are phosphorylated (or ppl9 and ppl2) and are found associated with 
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the viral membrane. The second viral protein that is similarly 
modified is reverse transcriptase (Lee et al., 1975; Hizi et al., 
1977). The reasons for these modifications are not entirely known. 
Lee et al. (1975) has suggested that phosphorylation is required for 
the enzymatic activity of reverse transcriptase. This has not been 
proven but it seems possible that this modification would be required 
to create the correct three dimensional stucture needed for the en-
zymatic activity. The reason for modifying pl2 and pl9 of MLV and RSV 
respectively is not known at this time. However, since Erikson et al. 
(1977) demonstrated that pl9 can be modified while still in the 
precursor form (Pr76). This result suggests that phosphorylation 
somehow influences the processing of Pr76. 
Other post-translational modifications of viral proteins seem to 
have some effect on the viral life cycle. Most noted of these are the 
virally induced cell-surface glycoproteins unrelated to env. This 
phenomenon was first described by Tung et al. (1976) while studying 
leukemic cells from AKR-strain mice infected with MLV. Friend strain 
murine leukemia virus (FeMLV) infected erythrocytes (Evans et al., 
1977) and Moloney murine leukemia virus (MoMLV) infected fibroblasts 
(Evans and Fan, 1979) also harbor glycosylated cell-surface proteins 
which are induced by MLV infection. 
By using a variety of in vivo labeling techniques, these cell 
surface antigens were identified as glycosylated gag proteins (Tung et 
al., 1976; Ledbetter et al., 1977; Buetti and Diggelmann, 1980b; Dick-
son et al., 1982). Irnrnunoprecipitation studies have identified that 
these surface proteins exists as two species with molecular weights of 
95 and 85 kDa. The results also suggest that gp85 is derived from 
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gp95 after proteolytic removal of plOgag (Ledbetter et al., 1978; Tung 
and Fleisnner, 1980; Dickson et al., 1982). Edwards and Fan (1980) 
demonstrated that gp95 is synthesized independently of Pr65gag from a 
precursor protein of 80 kDa, gPr809a9 . 
These glycosylated gag proteins do not appear in the viral par-
ticles but are present on the cell surface from which the virions were 
released (Aoki et al., 1972). It is unlikely that these glycoproteins 
are just an artifact since they are present on virtually all MLV in-
fected cells and exhibit an affinity for extracellular matrices (Fan 
et al., 1983). This affinity for these matrices may be a result of 
the extra amino acids found on the amino-terminus of gPr80. These ex-
tra .residues probably also ca~ry the signals required for glycosyla-
tion (Edwards and Fan, 1980; Dickson et al., 1984). Edwards and Fan 
(1981) went on to further isolate several mutant strains of MLV that 
are deficient in the production of the surface glycoproteins. Most 
but not all were also defective for viral production. They 
hypothesized that these proteins are therefore important in the virus 
life cycle. Other evidence suggests that the glycoproteins are prob-
ably not important. Swartzberg et al. (1983) and Fan et al. (1983 in-
dependently isolated mutants of MLV that are incapable of expressing 
these surface proteins but are capable of virus production. These 
mutants are also still capable of transforming the infected host. So, 
it is still not clear what function, if any, these surface 
glycoproteins play in the retroviral life cycle. 
CHAPTER II 
VIRION ASSEMBLY AND MATURATION 
Since Rous' famous discovery of a transmittable entity respon-
sible for tumor formation in chickens, many virologists of been 
diligently searching for analogous viruses involved in malignancies in 
mammals., especially humans. There are countless examples of 
retroviruses responsible for neoplasms in all mammals studied to date. 
But it is surprising to note there are only three known retroviruses 
that are capable of infecting the human population. Two of these are 
responsible for infectious leukemias, HTLV I and HTLV II, while the 
third (HIV), causes extensive cell death of the T4 helper cell popula-
tion of the immune system. 
In spite of the importance of these viruses as human pathogens 
and the need to understand their replication cycles, it is surprising 
that very little is known about the process of particle assembly and 
maturation. What little we do know is based on electron 
microscopy and gross analysis of replication defective mutants, 
mostly in MLV. The following discussion will review these mutants as 
well as describe the current working hypotheses of viral assembly and 
maturation. 
Theories on Assembly and Maturation 
The enormous size alone of the two volumes of the "RNA Tumor 
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Viruses: Molecular Biology of Tumor Viruses" text is evidence enough 
of the colossal amount of information that has accumulated concerning 
retrovirology. The two texts combine over 2,500 pages of valuable in-
formation. In contrast, what is known about particle assembly and 
maturation can be summed up in four pages (p 528, and 556-558 of 
Volume 1). 
As mentioned in Chapter 1, the outer membrane of the virion is 
derived from the host cell surface membrane and is studded with 
numerous glycoprotein projections or spikes. The proteins are syn-
thesized and processed in the rough endoplasmic reticulum and then are 
transported to the cell surface where they are incorporated into the 
viral envelope at the exclusion of all other host surface proteins. 
The exact mechanism for the specificity of viral glycoproteins is not 
entirely known but it is generally thought that the cytoplasmic tail 
of the glycoprotein interacts with gag precursor polypeptide or imma-
ture nucleocapsid. This proposed interaction does not seem essential 
for viral budding however because particles can be generated (although 
noninfectious) in the absence of the viral glycoproteins (Dickson et 
al., 1982). 
Many other investigators have also demonstrated that budding can 
occur in the absence of reverse transcriptase (Hanafusa et al., 1972; 
Eisenman et al., 1980; Dickson et al., 1982) and genomic viral RNA 
(Levin et al., 1974: Linial et al., 1978). However budding can bear-
rested by deleting the gag sequences or mutating them in such a way 
that Pr76 can not be processed. Thus, Dickson coined the term 
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"particle-making machine" since it is obvious that Pr76gag is the major 
and perhaps the only viral peptide required for budding (Dickson et 
al., 1982). 
With the above data in mind, many (Bolognesi et al., 1978; 
Bishop, 1978; and Dickson et al., 1982) have suggested the following 
model for type C particle assembly and maturation: (1) The viral env 
precursor polypeptides are synthesized on the endoplasmic reticulum so 
glycosylation can take place. After this modification, the 
glycoproteins are transported to the cell surface so they can be in-
corporated into the budding virion. The kinetics of processing the 
env precursor have shown Pr95env to be overproduced and only about 1% 
of the total synthesized product is actually incorporated into the 
virion (Bosch and Schwartz, 1984). The timing of Pr95env processing in 
vivo is not really known. (2) The gag precursor polypeptide is syn-
thesized on cytoplasmic ribosomes and then makes its way to the site 
of budding, by unknown mechanisms. Here the precursor products ag-
gregate with the amino-terminus associated with the cytoplasmic 
membrane and the carboxy terminus associated via pl2 (in RSV), with 
the viral genomic RNA. Because these proteins are aggregating, the 
immature particle begins to bud from the cytoplasmic membrane. (3) 
Also included in the aggregation is Prl809ag·~l with the associated 
tRNAtrp molecules (Panet et al., 1975b). (4) Once the immature virus 
buds from the membrane, the precursor polypeptides, Pr76gag and 
Prl809ag·~l, undergo proteolytic processing. It is believed that the 
condensing of the nucleocapsid (or viral maturation) is a result of 
this processing . 
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This simple model of assembly and maturation is easy to envision 
but much more difficult to prove. There is strong evidence that 
Pr76989 is the only peptide required for budding. Te evidence is only 
indirect since no one as yet has been able to express Pr76 by itsself 
and demonstrate viral budding. Two important questions have yet to be 
answered. Are viral maturation and precursor processing actually the 
same event? And, how is the gag precursor targeted to the site of as-
sembly? This site might be the cytoplasmic membrane or some inter-
cytoplasmic location as is the case with type B and type D 
retroviruses (Yoshinaka and Luftig, 1982). 
The Crucial Peptide for Buddin~. 
Bister et al. (1977) reported the first evidence that implicates 
Pr76 in budding in the avian retroviruses. They demonstrated that a 
nonproducing cell line transformed with avian myelocytomatosis virus 
produced a virus specific peptide of 110 kDa. This peptide was shown 
to be similar to Pr76989 in that it was immunoprecipitated with an 
anti-p27 antiserum. Further peptide analysis revealed that this cell 
line did not make Pr76 nor any of the processed gag proteins (pl9, 
plO, p27, pl2, pl5). These observations along with the fact that this 
defective virus was capable of being rescued by Rous associated virus 
type 1 suggests that the defect in virus production was due to a le-
sion in gag. Haymon et al. (1979) reported similar data on a non-
producing cell line transformed with avian erythroblastosis. 
The idea that Pr65989 in MLV or Pr76989 in RSV is the only peptide 
required for budding is strengthened by studies using temperature-
sensitive (ts) replication mutants of MLV and RSV. Mason et al. 
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(1979) described the isolation of three ts mutants whose lesions map 
to the gag gene. These mutants were identified by their reduced 
yields of labeled virions at the non-permissive temperatures. Pulse-
chase experiments revealed these mutants were delayed in Pr76 process-
ing. 
It is difficult, however, to find in the literature well charac-
terized mutations in which the lesions fall in the gag gene since most 
of the mutations are lethal. Goff and Lobel (1987) describe many 
spontaneous murine leukemia virus mutants and their mutational ef-
fects. However, its dramatic to note the few number of mutants iso-
lated that have an alteration in the gag coding region. This is again 
indirect evidence that the gag peptide is solely responsible for bud-
ding and virion production. What obviously needs to be done, is to 
express Pr76989 or Pr65989 by itself and determine if viral particles 
are released. 
Precursor Processing and Viral Maturation. 
There is substantial evidence that gag precursor processing and 
viral maturation (see p. 3) are closely linked (Vogt et al., 1975; 
Stephenson et al., 1975; VandeVen et al., 1978; Lu et al., 1979; 
Mooren et al., 1980; Yoshinaka et al., 1980; Manly et al., 1981; Dur-
bin et al., 1984; Katoh et al., 1985; and Katsumoto et al., 1987). 
It is clear that viral particles can not mature without coexistent 
processing of the gag precursor polyprotein. But it is not known 
whether cleavage of gag, pol, and env polyproteins immediately 
precedes or accompanies viral budding or maturation (Dickson et al., 
1982). If cleavage is required for maturation, and is dependent upon 
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the viral protease (Dickson et al., 1982), what activates the 
protease? As will be described later, one of the theories to explain 
mammalian host restriction of avian retroviruses is that the mammalian 
cells lack the required host protease that activates the viral 
protease (Dickson et al., 1982). Others have speculated that the gag 
precursors must associate in some way at the site of assembly to 
stimulate budding and maturation (Pepinsky et al., 1980; Dickson et 
al., 1982). 
Targeting of the gag Precursor Polypeptide. 
Although retroviruses require processing of the gag precursor 
for maturation, viral assembly can still occur in the absence of 
processing (Gazdar et al., 1971; Pinter and deHarven, 1979; and Ed-
hauer and Naso, 1984). Thus, the mature forms of the viral core 
proteins are not required for assembly. This is in line with the idea 
that the gag precursor polypeptide must be targeted to the site of as-
sembly were it interacts with other precursors to stimulate budding. 
With this in mind, many investigators have attempted to find the 
mechanism of targeting. 
Edbauer and Naso (1983) reported that Pr65989 of MuMLV binds 
rapidly and specifically to cytoskeletal elements in infected cells. 
They went on to demonstrate that a temperature sensitive (ts) mutant 
of MLV had increased amounts of Pr65989 associated with the cytoskele-
tal elements. They suggested that, "the majority of Pr65989 molecules 
in a cell exist in the membrane-bound form via plS and these peptides 
are direct precursors to the mature viral proteins." The 
cytoskeletal-associated proteins are then probably required for cor-
rect targeting of Pr65989 to the cell surface. 
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Other evidence has accumulated which shows MLV and probably all 
mammalian retroviruses to be myristylated at the amino terminal 
glycine of Pr65989 (Henderson et al., 1983). Rein et al. (1986) 
demonstrated by·using site directed mutagenesis that this acylation of 
MuMLV is required for the association of the gag protein with the 
plasma membrane and that this association is required for viral as-
sembly. On the other hand, all avian C-type retroviruses but one lack 
this myristic acid modification but are acylated with an acetyl group 
(Palmiter et al., 1979). Avian reticuloendotheliosis virus has been 
shown to be myristylated and it is known that this particular avian 
retrovirus can replicate in mammalian cells (Schultz and Oroszlan, 
1983; Weiss, 1982). Therefore it is easy to specul~te that myristyla-
tion must be important in targeting Pr76989 to the plasma membrane 
since other lipid-associated proteins can be similarly acetylated 
(Dickson et al., 1985). 
Another interesting experiment to note was performed by Bosch 
and Schwartz (1984). They used an inhibitor of glycoprotein transport 
(monensin) to study the processing of Pr95env. A startling result was 
reported with monensin treated infected cells. In these cells with 
arrested glycoprotein processing and targeting, viral particles were 
seen budding into intercellular vesicles. They suggest that targeting 
of the core precursors to the plasma membrane might result from some 
unidentified host protein. 
Phosphorylated gag Polyproteins. 
As mentioned in Chapter I, two types of post-translational 
modifications of the gag precursor have been observed but the func-
tions of the modified proteins remain obscure. The glycoproteins do 
not appear in the viral particle but are present on the cell surface 
of the infected host. The observed phenomenon of intracellular bud-
ding mentioned above, might be explained by glycosylated gag precur-
sors being required for transporting the direct core precursor 
polyproteins to the plasma membrane. 
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In addition, Schultz et al. (1979) suggested that the direct 
core precursor polypeptides were phosphorylated prior to cleavage. 
Since they have been able to identify a kinase activity in the viral 
particles, they speculate that the phosphorylation is required to ac-
tivate the cleavage events needed for viral maturation. This idea has 
been strengthened by the observations that avian myeloblastosis virus 
also harbors two protein kinases distinct from the viral oncogene 
products (Rosok et al., 1979). It has also been shown by in vitro 
phosphorylation that the gag precursor is modified at an amino acid 
residue within pl2 (Yoshinaka and Luftig, 1982; Sen at al., 1977). 
These results are similar to the observations of Naso et al. (1979). 
They too suggest that pl2, while still part of Pr659a9 , is phosphory-
lated and this apparently is related to rapid cleavage of Pr65gag and 
viral maturation. 
Host Restrictions on Replication 
An approach in elucidating viral assembly is to determine in 
detail the restrictions imposed by nonproducing cell lines such as 
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mammalian cells transformed with RSV. Svet-Moldavsky (1958) first 
demonstrated that RSV could infect mammalian cells and transform them. 
This observation was soon confirmed by a number of other investigators 
(Schmidt-Ruppin, 1959; Jenson et al., 1964; Munroe and Windle, 1963). 
These cells were determined to be true nonproducer cells since no 
virus particles were released when assessed by infectivity assays 
(Svoboda and Hlozanek, 1970; Weiss, 1982). The block in particle for-
mation was determined not to be a result of altered provirus structure 
since it was determined that virions could be rescued by membrane fu-
sion with uninfected avian cells (Svoboda et al., 1967; Shevliaghyn et 
al., 1969; Machala et al., 1970). Therefore, the avian cells must 
harbor the correct factors to induce virus production (Svoboda et al., 
1971). 
Von der Helm et al. (1980) and Vogt et al. (1982) did most of 
the pioneering work in pursuing the nature of the block in mammalian 
cells. They were able to show that the levels of Pr76989 in trans-
formed mammalian cells were dramatically reduced and Pr76 was not 
processed into the major core proteins. Therefore, they suggest two 
possibilites that could explain the block in replication. The first 
possibility is that the concentration of Pr76989 in these cells is too 
low to allow the correct intermolecular interactions required for par-
ticle formation. Therefore, the block must be at the level of 
transcription or translation. This is a plausible explanation since 
it is known that enhancer elements can be species or tissue specific 
(Banerji et al., 1983; Gillies et al., 1983; Varmus and Swanstrom, 
1985; Varmus and Swanstrom, 1985). The second possibility is that 
some avian host product is required for targeting the precursor to the 
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site of assembly and for pr~cessing. 
SV40 Expression Vector 
The use of the SV40 virus as a eukaryotic expression vector in 
mammalian cells has been well documented (Gething and Sambrook, 1981 
and 1982; Wills et al., 1983 and 1984). The advantages for using 
this viral system to express a cloned gene are numerous and diverse; 
1) The most obvious is, of course, the normal host of SV40 are mammals 
in particular primates. In tissue culture, investigators routinely 
use an African green monkey (Cercopithecus aethiops) kidney cell line, 
CV-1. Coincidentally, this cell line was established in 1964 to study 
RSV transformations (Jensen et al., 1964). 2) The naked DNA of SV40 
is infectious. This is important since the recombinant SV40 DNAs can 
be directly transfected into cell cultures. 3) The methods used for 
transfecting recombinant SV40 DNA have been worked out in great detail 
(McCutchan and Pango, 1968; Sompayrac and Danna, 1981; Luthman and 
Magnusson, 1983; Perez et al., 1986). 4) The late promoter (PL) used 
to drive expression of the subcloned genes is very strong (Gething and 
Sambrock, 1981). By driving expression of gag from this promoter in a 
recombinant SV40 vector, the levels of Pr76 in mammalian cells should 
be sufficient to address the question whether or not the block in 
replication in mammalian cells is because of poor expression. 5) The 
nucleic acid sequence has been determined (Reddy et al., 1978) which 
will greatly expedite the subcloning of the RSV gag sequences into the 
vector. 6) The SV40 genome replicates independently of the host 
chromosome. 
Two important matters must be considered when using this 
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virus as an expression vector. First in order to propagate the recom-
binant viruses, the total size of the circular DNA must be between 70% 
and 100% of the wild type SV40 genome although the actual size limita-
tion have not been worked out. This is important for DNA packaging of 
the recombinant DNA. The other point is that the recombinant virus 
will be replication defective since the late genes needed for virion 
assembly will be replaced with the foreign DNA. In order to rescue 
the recombinant virus, the late viral products must be supplied by 
cotransfecting DNA from a helper virus. When the vector DNA and the 
helper DNA are cotransfected into CV-1 cells, complementation between 
the early region of the vector molecule and the late region of the 
helper molecule allows for correct replication and packaging of both 
DNA molecules. The viruses can then be harvested and used to infect 
virtually 100% of a fresh monolayer. This is also important in 
analyzing the foreign product since at best only about 5% of the 
monolayer is actually cotransfected. 
SV40 Replication Cycle: A Mini Review. 
The SV40 replication cycle is perhaps the best understood of the 
eukaryotic viruses to date. Therefore, this minireveiw will only dis-
cuss the important details pertaining to the use of SV40 as a 
eukaryotic expression vector. 
SV40 and the closely related polyoma virus belong to the papova 
viral family. They are small DNA tumor viruses that replicate in 
monkey and mouse cells, respectively. SV40 was first identified in 
1960 in a batch of contaminated polio vaccines prepared from Rhesus 
monkey cells. It was described as a noncytopathic virus present in 
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Rhesus monkey cells that produced strong cytopathic effects when cul-
tured in African green monkey kidney cells (Sweet and Hilleman, 1960; 
Fried and Prives, 1986). 
As reviewed by Freid and Prives (1986), the nucleic acid of SV40 
is a double-stranded circular DNA molecule consisting of 5,297 base-
pairs. The genomic organization is divided into three distinct 
regions. The two largest regions, comprising nearly half the genome 
each, encode the products required for viral replication. These two 
regions are bidirectionally and differentially expressed, during the 
course of an infection, from the opposite strands and are termed the 
early and late regions. The third region is a relatively small region 
located between the early and late regions. Most of the regulatory 
sequences needed for viral gene expression (enhancers and promoters) 
and DNA replication (origin of replication) are found in this region. 
The early viral products found in an SV40 infection are the 
large "T" and small "t" antigens (so named for their tumor inducing 
properties). The coding regions for these two proteins were mapped 
and determined to originate from the same early promoter, PE. They 
were also found to share portions of the same reading frame and thus 
must originate from a spliced mRNA. In fact, the first documented ex-
amples of such splicing originated with this virus (Shenk et al., 
1976; Berk and Sharp, 1978). 
Early transcription of the "T" antigens not only relies on the 
upstream "TATA" box, but also the 21 bp repeats and the 72 bp enhancer 
elements. It is not known but it is suspected that host Spl, along 
with other factors not yet identified, interacts with the enhancer and 
the three 21 bp repeats to activate early transcription (Dynan and 
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Tj ian, 1983). 
The major product from the transcripts is the large "T" antigen. 
This early gene product begins to accumulate soon after viral penetra-
tion and their cellular concentration increases for about 8-10 hours 
until DNA replication begins (Schirrnbeck and Deppert, 1987). This 
particular protein is perhaps the best understood eukaryotic regulator 
protein. It has been shown to be involved in SV40 DNA replication, 
late gene expres~ion, cell transformation, host range restriction, and 
induction of host DNA replication factors that are required for v~ral 
DNA replication (Fried and Prives, 1986). The small t antigen is not 
as well characterized and will not be discussed in futher detail. 
Elucidating the strategy for regulating late gene expression 
remains a difficult task. It is known though that expression of the 
late region relies on DNA replication and the activity of the large T 
antigen. The origin of replication (ori) has been mapped to a region 
between nucleotides 5208 and 30. DNA sequencing has revealed a 27 bp 
perfect inverted repeat adjacent to a long (17 bp) stretch of A/T 
nucleotides. This region (nucleotides 5208 to 30) also contains one 
of the T antigen binding sites (site II).. This is not surprising 
since it has been demonstrated numerous times that the only viral 
product needed for DNA replication is the T antigen. It has been sug-
gested that this protein acts in concert with host alpha-primase to 
initiate replication. 
Once DNA replication has begun, T antigen is no longer needed 
since it is only required for initiation of DNA replication and not 
DNA synthesis. Some have suggested that the 21 bp repeat as well as 
the 72 bp enhancer region are required for replication but this has 
not been fully worked out (Murakami et al 1986; Fried and Prives, 
1986). 
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Late gene expression initiates after DNA replication. It is not 
known if express·ion is stimulated, by the act of DNA replication melt-
ing the supercoiled DNA complex, by the T antigen activating the late 
promoter maybe at the enhancer region, by the T antigen stimulating 
the expression of a host product which is required to act in trans, or 
by some type of transcriptional attenuation (Hay et al., 1982; Brady 
and Khoury, 1985; Fried and Prives, 1986). 
The late products of SV40 infection, VPl, VP2, and VP3, are re-
quired for particle formation and DNA packaging. VPl has been 
reported as being responsible for SV40 chromatin spacing, a possilbe 
requirement for packaging (Blasquez et al., 1986). But, the roles of 
the other products are_ unclear. Like most other viruses, the 
mechanisms of particle formation remain obscure. 
In recent years a new late viral product has been discovered. 
This protein, called the "agnoprotein," was first suspected after the 
nucleic acid sequence was deduced. It was later found in in the 
perinuclear cell fraction and seems to bind to DNA cellulose. The ex-
act role this product plays in the viral life cycle is not known. 
But, it has been suggested that this protein plays an important role 
in late gene expression and possibly viral assembly (Fried and Prives, 
1986). 
I have decided to use a molecular genetics approach to begin to 
elucidate the problem of particle formation in mammalian cells. This 
is a very important project because elucidating the block in particle 
formation in mammalian cells will lead to a better understanding of 
the normal process of particle formation in the natural host and pos 




Materials and Methods 
Organisms 
All plasmids were propagated in Escherichia coli strain DH-1 (F-, 
recAl, endAl, gyrA96, thi-1, hsdR17(r~, m~), supE44, relAl?, lambda") 
(Hanahon, 1983) on L.B. agar plates + 35ug/ml. ampicillin (see 
appendix). E. coli transformants were stored in L.B. broth+ 25% 
glycerol at -80°C. 
The expression and characterization of the recombinant SV40 vec-
tors were studied in CV-1 cells (Jenson et al., 1964), a continuous· 
line of African green monkey kidney cells that are permissive for SV40 
replication (Acheson, 1981), and Cos-1 cells, an SV40 transformed CV-1 
cell line that is constitutive for T-antigen expression (Gluzman, 
1981). Both cell lines were purchased from ATCC (Rockville, MA) and 
passaged not more that ten times in these experiments. Both cell 
types were grown in Dulbecco's modification of minimal essential 
medium (MEM) (Flow laboratories, Inc., Mclean, Va). The medium was 
supplemented (per liter) with 1.68 g NaHC03 , 1.2 x 10"5 g penicillin G 
(20 Units), and 1.0 x 10"5 g streptomycin. After the medium was 
sterilized by filtration through a 0.45 urn nitrocellulose membrane, 
heat-inactivated calf and fetal bovine sera (Hyclone Laboratories, 
Inc., Logan Utah) were added to 6% and 3% respectively (growth 
medium). All mammalian cell cultures were incubated at 37°C in 5% C02 . 
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Long Term Storage and Thawing of 
Eukaryotic Cell Cultures 
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To store CV-1 and Cos-1 cells, the cell monolayers were detached 
with 0.05% trypsin. As soon as the cells were released, the trypsin 
was diluted in nine volumes of growth medium (as described above). 
The cells were pelleted by low speed centrifugation at 800 rpms for 15 
minutes in an IEC model CL clinical centrifuge at room temperature. 
The cells were then washed twice in 10 ml of growth medium. The cells 
were again pelleted and resuspended in 0.25 ml of growth medium per 
1.0 x 107 cells and colled on ice. While the cells were pelleting, the 
freezing medium was made as follows: 11 parts MEM: 5 parts Dimethyl 
sulfoxide (DMSO) (Sigma Chemical Co., St. Louis, Mo): 4 parts fetal 
bovine serum. The freezing medium was then added to the cell suspen-
sion one drop at a time to a final concentration of 50%. After the 
cells were resuspended in the freezing medium, 0.5 ml aliquots were 
added to each cryotube and placed at -137°C as quickly as possible. 
To thaw the cells, the frozen cultures were removed from the 
freezer and brought to room temperature as quickly as possible by 
warming in a 50°C water bath only until the ice had disappeared. 
Growth medium (0.3 ml) was added one drop at a time, then all the 
cells were added to a tissue culture flask + 30 ml growth medium. The 
medium was changed after 24 hr to remove any residual traces of DMSO. 
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DNAs and Viruses 
The Prague C gag gene used in this investigation was derived 
from a recombinant plasmid pATV-8, which contains the entire genome of 
Rous sarcoma virus (Schwartz et al., 1983). The SV40 late region re-
placement vector, dl2005 (Sleigh et al., 1978), used for the expres-
sion of RSV gag and all other subsequent mutations in the gag se-
quences, was subcloned into a derivative of pBR322 for propagation in 
E. coli (pQD). SV40 late functions were provided by a early deletion 
mutant, dllOSS (Pipas et al., 1982 and 1983). Both SV40 DNAs were 
generously provided by Dr. Mary-Jane Gething and Dr. Joe Sambrook 
(University of Texas Health Science Center, Dallas Tx.). A recom-
binant SV40 vector carrying the RSV env gene was used as a positive 
control in all experiments unless otherwise noted. This vector, 
designated SV.KX (see Fig. 7), is essentially the same as SV.KB (Wills 
et al., 1984). The only difference between the two vectors is that 
SV.KX retains the original RSV Xba I site (downstream of the env 
coding sequence) adjacent to the Bam HI site whereas SV.KB does not 
(Wills, pers. comm). 
DNA Manipulations 
Restriction Endonuclease Digestions 
Restriction endonucleases were prepared and used according to 
manufacturers published protocols. DNA was purified away from con-
taminating proteins by extracting once in buffer equilibrated 
phenol:chloroform (1:1) (see, Phenol Chloroform Extraction of Nucleic 
Acids). The DNA concentrations were estimated by comparing the band 
intensities with known standards (Lambda Hindiii standards, 20 ugjml, 
New England Biolabs, Beverly, Ma.) after agarose gel electrophoresis 
and staining with ethidium bromide (see below) (Sigma Chemical Co., 
St. Louis, Mo) 
Agarose Gel Electrophoresis 
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DNA Fragments were analyzed by agarose gel electrophoresis 
(Maniatis et al., 1982). The standard gel used in this investigation 
contained 0.8% agarose (International Biotechnologies, Inc. (IBI), New 
Haven, Ct.) in Tris-Acetate Buffer (see Appendix) with 0.5 ug/ml 
ethidium bromide (Sigma Chemical Co. St. Louis, Mo.). The same Tris-
Acetate buffer was used for the electrophoresis buffer and also con-
tained 0.5 ug/ml ethidium bromide.• Gels were run at a constant 13.3 
volts/em. 
DNA fragment sizes were estimated by visually comparing and 
curve fitting their electrophoretic mobilities to DNA size standards 
(Lambda DNA digested with Hind III, New England Biolabs, Beverly, Ma). 
Phenol-Chloroform Extractions 
of Nucleic Acids 
DNA was always extracted as follows. The approximate volume of 
DNA was estimated and the final concentration of NaCl was adjusted to 
0.1 Musing a stock solution of 5M NaCl. The nucleic acid concentra-
tion was also adjusted to 30 ug/ml using a stock solution of 30mg/ml 
tRNA (Sigma Chemical Co. St. Louis, Mo.). The nucleic acids were then 
extracted once by adding an equal volume of a 1:1 ratio of a Tris-HCl, 
pH 8.0, buffer saturated phenol:chloroform (Maniatis et al., 1982). 
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The mixture was thoroughly vortexed and the two organic and aqueous 
phases were separated by centrifugation for 2 minutes at 16,500 x g. 
The upper aqueous phase was transferred to a clean tube and extracted 
twice in a like manner with chloroform to remove any residual traces 
of phenol. The DNA was then precipitated by adding two volumes of 
100% ethanol. The DNA was pelleted by centrifugation at 16,500 x g 
after the suspension was allowed to set for at least 15 minutes at 
-20°C. The ethanol was removed by drying the pellet in a vacuum cham-
ber. The DNA was dissolved in an appropriate volume of TE buffer 
(lOrnM Tris-HCl pH 8.0, lrnM EDTA pH 8.0) + 20 ug/ml RNAse A. 
Plasmid Isolations 
Many protocols have been developed for the isolation of plasmid 
DNA. I chose to use the method of lysis by alkali as described by 
Maniatis et al. (1982). When screening for transformants, mini-
lysates were prepared as follows. Four ml of L.B. broth plus the an-
tibiotic of choice (see Appendix A) was inoculated with a single 
colony. The cultures were incubated overnight at 37°C with vigorous 
shaking. 
Bacterial cells were harvested by centrifugation at 16,500g for 
2 minutes. The pellets were completely resuspended in 100 ul of Solu-
tion I (50 rnM glucose, 25 rnM Tris-HCl pH 8.0, 10 rnM EDTA pH 8.0, and 5 
mg/ml lysozyme). The cultures were incubated at room temperature for 
5 minutes to allow the cell wall to be digested by the lysozyme. The 
integrity of teh remaining spheroplast was retained by the osmolarity 
of 50 rnM glucose. Two hundred microliters of freshly prepared Solu-
tion II (0.2 N NaOH, and 1% SDS), was then added, mixed, and allowed 
51 
to set on ice for 5 minutes. The SDS solubilizes the cell membrane 
which is accessible due to the weakened cell wall resulting. Both the 
chromosomal DNA and plasmid DNA were then denatured by the alkaline 
conditions. One hundred and fifty microliters of Solution III (3 M 
KOAc, pH about 6.0, was prepared as follows; to 60 ml of 5 M KOAc, add 
11.5 ml of glacial acetic acid and 28.5 ml H20) were added to the 
lysates to allow reannealing of the plasmid DNA. The chromosomal DNA 
which was nicked and denatured by the protocol does not reanneal under 
these conditions and is removed along with the cell debris by 
centrifugation at 16,500g for 5 minutes. The plasmid DNA was then ex-
tracted as described above and resuspended in 50 ul of TE buffer with 
20ug/ml RNAse A. 
"Midi-Prep" DNA was prepared from 50 ml cultures as described 
above except with 1 ml of Solution I, 2 ml Solution II, and 1.5 ml 
Solution III. After the DNA was extracted and pelleted, it was dis-
olved in 100 ul TE buffer plus 20 ug/ml RNAse A. 
For large preparations of plasmid DNA (or "Maxi-Preps"), 25 ml 
of L.B. medium was inoculated with 0.1 ml of an overnight culture and 
incubated at 37°C with vigorous shaking until the O.D. 600 reached 0.6. 
This culture was added to 500 ml L.B. medium with the appropriate an-
tibiotic. The culture was incubated at 37°C with vigorous shaking for 
2.5 hr. Plasmid DNA was selectively amplified by adding chloram-
phenicol to 170 ug/ml. Chloroamphenicol amplifies the number of 
copies of plasmid by inhibiting host protein synthesis. In the ab-
sences of protein synthesis, replication of the plasmid carrying the 
Col EI replicon continues whereas chromosomal DNA replication is in-
hibited. The cultures were incubated for another 12 to 16 hr at 37°C 
with vigorous shaking. 
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Lysis of the cultures were carried out as described above except 
with 10 ml of Solution I, 20 ml Solution II, and 15 ml Solution III. 
Plasmid DNA was precipitated with an equal volume of isopropanol and 
pelleted at 16,500g for 15 minutes. The pellet was resuspended in 3.2 
ml TE buffer and plasmid DNA was purified by centrifugation to equi-
librium in cesium chloride-ethidium bromide density gradients. 
Purification of Plasmid DNA. 
Supercoiled plasmid DNA can be purified due to its buoyant den-
sity in ethidium bromide-cesium chloride gradients. The gradients 
were prepared by adding 1 g of cesium chloride and 100 ul of ethidium 
bromide (10 mg/ml) to every ml of DNA followed by centrifugation for 
16 to 18 hr at 60,000 rpm in a Beckman vTi-65.2 rotor at 20°c (Maniatis 
at al., 1982). 
After centrifugation, two DNA bands could be seen with ultra-
violet irradiation. The upper band contains linear and open circular 
plasmid DNA and the lower band contains closed circular plasmid DNA. 
The lower band was removed with a 20 gauge needle and the ethidium 
bromide was extracted with water-saturated N-butanol (Maniatis et al., 
1982). The DNA was precipitated by adding two volumes of H20 and then 
two more volumes of 100% ethanol (final concentration of 70% ethanol). 
After centrifugation to pellet the DNA, it was resuspended in 1 ml. TE 
buffer. The concentration was estimated by comparisons to DNA stan-
dards after agarose gel electrophoresis. 
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Subcloning and In Vitro Mutagenesis 
The RSV gag coding sequence (nucleotides 380 to 2485) is con-
tained within a 2485 bp Sac I-Hind III fragment (nucleotides 255 to 
2740 respectively). This fragment was modified by adding one dephos-
phorylated Cla I linker (d[CATCGATG]) to the Sac I site with T4 DNA 
ligase after blunt-ending the fragment with the Klenow fragment of E. 
coli DNA Polymerase I. The fragment was subcloned into pJC-2, a 
derivative of pAT153 missing the Eco RI site, in place of the Cla 
I-Hind III fragment (Twigg and Sheratt, 1980). The resulting plasmid 
was further modified by the addition of one Xba I linker (d[CTCTAGAG]) 
to the Hpa I site in RSV to facilitate further manipulations. This 
plasmid was designated pGAG. 
SV40 DNA lacking the late region was obtained from a derivative 
of SVEHA3 (Gething and Sambrook, 1982) in which the Hpa II site was 
modified by the addition of a Cla I linker (see above). The vector 
was further modified by the addition of an Xba I linker (see above) 
adjacent to the Bam HI site following Klenow treatments. The 3056 
base-pair SV40 Cla I-Cla I fragment was gel purified and subcloned 
into the unique Cla I site of pGAG. The resulting plasmid was desig-
nated pSV.GAG. Correct orientation of the SV40 DNA was confirmed by 
restriction analysis. This construction leaves a functional SV40 late 
promoter to drive transcription of the inserted gag sequences (Brady 
et al., 1982). 
Because pSV.GAG is approximately 105% of the size of wild type 
SV40 DNA and borders, on the size limit for SV40 packaging (Elder et 
al., 1981), further manipulations were carried out to reduce the size 
of pSV.GAG. For this, a 1729 base-pair Nde I-Kpn I fragment from 
dl2005, a viable early deletion mutant, was ligated in place of the 
wild-type fragment in pSV.GAG. This mutant has a 230 base-pair dele-
tion that removes the intron (nucleotides 4639 to 4875) in the early 
region of the SV40 genome (Pipas et al., 1980 and 1983). The result-
ing construction was designated pASV.GAG and is approximately 100.5% 
the size of the wild-type SV40 genome (see Fig. 7). 
To introduce deletions into the 3' end of gag, p~SV.GAG was cut 
with Eco RV at the unique site in pJC-2 which is adjacent to gag. 
The linear DNA was digested for various amounts of time with the 
double strand specific Bal31 exonuclease. The digestions were 
quenched by the addition of EGTA to 1 mM; extracted with phenol-
chloroform, and the DNA blunt ended with Klenow. The DNA was cir-
cularized by ligation at low DNA concentrations (4ug/ml.) in the 
presence of Xba I linkers and used to transform E. coli DH-1 cells 
(see below). Clones were screened for the presence of Xba.I sites in 
the plasmids and the approximate size of the deletions was estimated 
by restriction analysis. These deletion mutants were constructed and 
generously provided by Dr. J.W. Wills (Louisiana State University 
Medical Center Shreveport, Shreveport LA) 
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It was also of interest in this investigation to determine 
whether or not p27 could induce viral budding if it was expressed by 
itself in the SV40 vector. In order to facilitate the· subcloning into 
the vector, the p27 coding region was first subcloned into the plasmid 
pAT153 as follows. The plasmid pATV-8 which contains an infectious 
clone of Rous sarcoma virus was cut to completion with Rsa I and the 



















Figure 7. Generalized structure of three SV40 late 
region replacement vectors used for the expression of RSV 
specific poylpeptides in CV-1 cells. The region of gag which 
codes for the amino terminus of Pr76 is located near the Cla 
I site of the vector p6SV.GAG . Three in vitro mutations were 
created in the gag coding sequence with the Bal 31 ex-
onuclease starting at the unique Eco RV site. The ap-
proximate end points of the deletions are indicated by the 
black arrows. The region of the coding sequence which codes 
for the amino terminus of p27 is located near the Cla I site 
of pSV.p27 . The plasmid sequences of both these vectors are 
between the early and late regions of the SV40 genome and 
must be removed with the appropriate enzyme prior to trans-
fections. The region of env which codes for the amino ter-
minus is located near the Kpni site of the vector pSV.KX. 
The plasid sequences are located between the two Kpn I sites. 
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1172 bp was purified by electroelution. The blunt ends were modified 
by the addition of Cla I linkers (see above) with T4 DNA ligase. The 
DNA was then digested again with Cla I and Bam HI (see Fig. 24). This 
fragment was again purifed by electroelution and ligated at 4 ug/ml 
overnight at 15°C into the corresponding sites in pAT153. This plasmid 
pAT.p27 was used not only as an intermediate to facilitate the sub-
cloning into the SV40 vector but also as a probe to detect p27 se-
quences in Southern hybridizations. This plasmid was constructed and 
generously provided by Chris Mhor. The SV40 sequences were introduced 
into this plasmid by isolating the 3000 bp Cla I-Cla I fragment of 
pSV.KX and ligating the frament into the unique Cla I site of pAT.p27 
with T4 DNA ligase. The result.ing pl~smid, pSV.p27, was digested with 
Bam HI to remove the plasmid sequences prior to transfection. After 
purifing the vector sequences (SV40 and p27), the linear fragment was 
circularized with t 4 DNA Ligase and the used to transfect CV-1 cells. 
Transforming Competent Escherichia coli DH-1 
Preparation of Competent E. coli DH-1 cells. E. coli DH-1 cells 
(Hanahan, 1983) were grown overnight in 3 ml of L.B. medium. One 
tenth ml of this culture was used to inoculate 10 ml of L.B. broth and 
incubated at 37°C until the O.D. 600 reached 0.2. Five ml of this cul-
ture was subcultured into 400 ml of prewarmed L.B. broth and again in-
cubated at 37°C until the O.D. 600 reached 0.2. · The cultures were 
chilled on ice for 10 minutes and the cells harvested by centrifuga-
tion at 5000 rpm in a GSA type rotor for 10 minutes at 4°C. The cells 
were washed in 200 ml of Transformation Buffer X (50 mM CaC12 , 15% 
glycerol, and 10 mM MOPS, pH. 6.6) at 4°C. The cells were pelleted 
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again and resuspended in 20 ml of Transformation Buffer X and were 
split into 200 ul aliquots. The cells were then quickly frozen on dry 
ice and methanol and stored at -70°C. 
Transformation of Competent E. coli DH-1 Cells. The mechanism 
of transformation in E. coli is not well understood. But the protocol 
for transformation is widely used. It is believed the calcium along 
with a heat shock are the major components of E. coli transformations. 
Br~efly, 200 ul of competent E. coli DH-1 cells (see above) were 
thawed at room temperature for 10 minutes. After the cells were then 
chilled in ice water for 10 minutes, up to 25 ng of DNA was added and 
further incubated on ice for 10 minutes. Heat shock was done by plac-
ing the cells at 37°C for 5 minutes then adding 0.8 ml prewarmed L.B.· 
broth. The culture was incubated at 37°C for 30 minutes then plated 
onto L.B. agar plates containing the appropriate antibiotic and in-
cubated inverted ov~rnight at 37°C. 
Southern Hybridizations 
Southern hybridizations were performed as described by Southern 
(1975). After agarose gel electrophoresis, the DNA was fragmented by 
soaking the gel in several volumes of 0.25 M HCl for 15 minutes at 
room temperature for minigels (2' x 3' x 1/4'), or 30 minutes for 
preparative gels (4' x 5.5' x 1/2'). The DNA was then denatured to 
single stranded DNA by soaking the gel in 0.5 M NaOH, 1 M NaCl for the 
same time. The gel was neutralized in 0.5 M Tris-HCl, pH 7.7, 3M 
NaCl for 15 or 30 minutes. 
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Southern Transfer of DNA to Nitrocellulose. The DNA was blotted 
onto nitrocellulose paper, type BA85 (Schleicher & Schuell Inc., Keene 
N.H.) as follows. One blotting pad (Gel Blot Paper GB004, Schleicher 
& Schuell) was saturated with 20 X sse buffer (see appendix). One 
piece of Whatman 3 MM paper was cut just smaller than the blotting pad 
and placed on top of the pad followed by the treated gel. Water 
saturated nitrocellulose paper (cut just slightly larger that the gel) 
was carefully placed on top of the gel. Air bubbles were worked out 
with a gloved hand. One piece of 3 MM paper and 3-4 em of paper 
towels were then placed on top followed by a 200 g weight. 
The capillary action provided by the paper towels pulls the SSe 
buffer up through the nitrocellulose. The single-stranded DNA is 
carried along with the buffer up through the gel and is bound by the 
nitrocellulose. After 3-4 hours, to overnight for larger gels, the 
nitrocellulose was marked for orientation and peeled away from the 
gel. It was then soaked in 6 X sse buffer for 5 minutes prior to 
baking for 2 hr at 80°e under vacuum. The filters can know be stored 
until needed in an air tight bag at room temperature. 
Before hybridizing the 32P-labeled probe DNA with the filters, 
the filters were prehybridized overnight at 42°e in a sealed bag with 5 
ml of prehybridization buffer (see Appendix D) to block nonspecific 
binding of the probe DNA. 
The 32P nick-translated probe DNA (see below) was boiled for 5 
minutes then quickly chilled in ice water. The probe (500 ng of DNA) 
was injected into the sealed bag using a 27 gauge needle. After the 
bag was resealed, the probe was hybridized to the bound DNA for 24 to 
36 hr at 42°e. After sufficient hybridization, the filters were 
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removed from the bag and any unbound probe DNA was washed off with 
three 5 minute washes with 2x SSe buffer, 0.5% SDS at room tempera-
ture. Any weakly bound probe DNA was washed off under high stringency 
conditions. This consisted of two thirty minute washes in O.lx sse, 
0.5% SDS at 68°e (in the presence of formamide) (Maniatis et al., 
1982). 
The filters were placed next to a preflashed X-ray film (see 
Fluorography) and two intensifying screens (Dupont). The autoradiog-
raphy was carried out from 15 minutes to 3-4 days, depending on the 
strength of the probe, at -80°e. The exposed film was developed ac-
cording to the manufacturer's protocols. 
32p Nick-Translation. Five tenths ug of probe DNA were nicked 
with a dilute sample of DNAse ~ that was previously titrated to a con-
centration that would nick plasmid DNA to linear form in 1 hr at 15°c 
(approximately 0.1 ugjml). This dilution resulted in plasmid DNA that 
had only a few nicks per molecule. The nicked probe DNA was simul-
taneously incubated with 1 unit of E. coli DNA Polymerase I in the 
presence of 50 uei 32P-deTP (specific activity of 619 eijrnrnol, New 
England Nuclear, Boston, Ma.),2 rnM dATP, dTTP, and deTP, and Nick-
translation buffer (see Appendix D) for 2.5 hr at 15°e. 
The percent incorporation of radiolabeled nucleotides into 
nucleic acid was calculated by adsorption to DE-81 filters as 
described by Maniatis et al., (1982). Briefly, 0.5 ul of the nick-
translation reaction was spotted onto two DE-81 Filters (Whatman) and 
dried. One of the filters was washed three times for 5 minutes each 
in 0.5 M Na2HP04 . The salt was removed by washing once for 1 minute in 
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H20. Finally the filters were washed once for 1 minute in 95% ethanol 
and dried. Both the unwashed filter (corresponding to total radioac-
tivity) and the washed filter (total radioactivity incorporated into 
nucleic acid) were counted in 3 ml of liquid scintillation fluid in a 
liquid scintillation counter. 
The unincorporated nucleotides were removed from the DNA by 
precipitating the DNA with 1/10 volume of 3 M sodium acetate and one 
volume of isopropanol. After the pelleted DNA had been dried, the DNA 
was resuspended in 1 ml of TE buffer and stored at -20°C. 
VIRAL INFECTIONS AND DNA TRANSFECTIONS 
SV40 Infections 
SV40 virus stocks were made by freezing (-20°C) and thawing 
transfected or infected plates three times. Once a fresh monolayer 
reached a confluency of 80%-90%, the medium was removed and 0.5 ml of 
the virus lysate was added. The virions were allowed to infect the 
monolayer for 30 minutes at 37°C. The lysate was then removed and 
fresh medium was added and the cells were incubated at 37°C. 
SV40 DNA Transfections 
Before transfecting the recombinant SV40 DNAs, the bacterial se-
quences (pJC-2) were removed by Xba I digestion of pASV.GAG or Kpn-I 
digestion of pSV.KX. The SV40-gag or SV40-env sequences were agarose 
gel purified (Maniatis et al., 1982) and circularized by ligation at 
low DNA concentrations (4 ugjml). 
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Virions carrying the recombinant SV40 DNAs were produced in CV-1 
cells by complementation with a co-transfected SV40 helper DNA 
(dll055) using a modification of the method of Sambrook and Gething 
(1982). Tissue culture plates (60mm) were seeded with 2.5 x 105 cells 
and incubated at 37°C in 5% C02 . When the monolayer became ap-
proximately 80% confluent, the cells were washed twice in phosphate 
buffered saline (PBS) and twice in tris buffered saline (TBS) (see Ap-
pendix A). Three tenths ml of TBS containing 120 ng circularized vec-
tor DNA, 36 ng helper DNA, and 300 ug DEAE-DEXTRAN (McCutchan and Pan-
gano, 1968) were added to the monolayers. The cells were then in-
cubated at 37°C, 5% C02 . The DNA was removed after 60 minutes and the 
plates were washed once with TBS, once with PBS and then growth medium 
containing 100 uM chloroquine (Luthman and Magnusson, 1983) was added 
for 4 hr at 37°C. The plates were incubated in medium without chloro-
quine for 4-7 days or until cytopathic effects were observed. 
Extraction of SV40 DNA 
SV40 DNA was extracted by the method of Hirt (1967). The 
monolayers (60 mm plate) were washed twice with cold PBS and drained. 
400 ul of lysis buffer (0.6% SDS, 10 mM EDTA, pH 7.4) were added to 
the plates and allowed to incubate for 20 minutes at room temperature. 
The lysates were scraped with a rubber policeman into a microfuge tube 
and the final NaCl concentration was adjusted to 1.56 M with 5 M NaCl. 
The tubes were inverted 10 times gently to mix the salt and lysate 
without shearing or detaching the DNA from the nuclear membrane. The 
DNA was allowed to precipitate overnight, then the chromosomal DNA was 
pelleted with the cellular debris by microcentrifuging at 16,500g for 
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8 minutes at room temperature. The supernatant was removed and RNAse 
A was added to 10 ugjml and incubated at room temperature for 30 to 60 
minutes. The DNA was extracted as described earlier and precipitated 
with one tenth volume of 20% potassium acetate and 2 volumes of 100% 
ethanol. The DNA was pelleted by centrifugation and dried under 
vacuum. The DNA was then resuspended in 50 ul TE containing 20 ugjml 
RNAse A. 
DNase I Protection 
In order to test whether or not both the vector and helper DNAs 
were packaged into DNase I resistant virus particles, 70-80% confluent 
monolayers (100 mm plates) were cotransfected for 1 hour followed by a 
4 hr chloroquine treatment. The monolayers were then digested for 1 
hr with DNase I as described in the DNA replication experiments to 
degrade .any DNA not ingested by the cells. SV40 DNA (vector or 
helper), either in released particles or still within the monolayers 
was harvested at 89 hr post-transfection as follows. The medium was 
removed and stored at -20°C overnight. The monolayer was gently 
scraped off the plates in 1 ml of RSB buffer (100 mM tris-Cl, pH 7.4, 
10 mM KCl, and 1.5 mM MgC12) using a rubber policeman. The cells were 
then frozen at -20°C overnight (Stow et al., 1983). The cells were 
then thawed at room-temperature and lysed by five 2 second bursts of 
sonication. One tenth volume of 13% deoxycholate and 0.1 ml of 0.25% 
trypsin were added to both the cell lysate and the culture medium and 
allowed to incubate at room-temperature for 20 minutes to disrupt any 
membrane bound vesicles that might have formed. SV40 particles have 
previously been shown to be resistant to this concentration of trypsin 
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(Khoury and Lai, 1979). The cell lysates were each split into four 
0.5 ml aliquots. To the first was added 1 ug of plasmid (pUC19) DNA 
(to check for DNase I activity) and 50 ug/ml of DNAse I. The second 
alquot received 1 ug plasmid DNA only. The third sample received 50 
ug/ml DNAse I and the fourth was left untreated. Any unprotected DNA 
was degraded by incubating these samples for one hour at 37°C. The 
DNase I was then inactivated by adding EDTA pH 8.0 and SDS to 1 mM and 
0.6% respectively. SV40 particles were then disrupted by adding 
Proteinase K to 500 ugjml and incubating at 37°C for two hours. The 
DNA was purified by two phenol-chloroform and two chloroform extrac-
tion and concentrated by precipitation with two volumes of 100% 
ethanol. The DNA was pelleted by centrifugation at 16,000 x g dried 
and resuspended in 20 ul of TE buffer. 
Meanwhile, the medium was clarified by centrifugation at 10,000 
x g for 10 minutes at 4°C. SV40 particles were concentrated by 
centrifugation in an SW41 rotor for 3 hr at 122,000 x g. The pellets 
were gently resuspended overnight in 0.5 ml of RSB buffer at 4°C by 
gentle agitation. The samples were split into two 0.25 ml aliquots 
and 1 ug of plasmid DNA was added to each DNAse I was added to one 
of the samples as before and incubated at 37°C for one hour. The DNAse 
I was inactivated and the DNAs were purified as described above. 
Fifteen percent of each extract were digested with Kpn I and Xba 
I to distinguish between helper and vector DNA molecules. The DNAs 
were transferred to nitrocellulose after agarose gel electrophoresis 




Viral specific proteins and their locations were identified by 
indirect immunofluorescence. CV-1 or Cos-1 cells were grown in 35 mm 
plates and stained after 60 hr or until cytopathic effects (CPE) were 
observed (usually 140 hr post-transfection). The monolayers were 
washed twice with PBS and fixed with 95% ethanol: 5% acetic acid for 
0.5 to 2 hr at -20°C. The fixative was removed and the monolayers were 
washed once with PBS+ 0.1% bovine serum albumin (BSA). Fifty ul of 
primary antibody (rabbit anti-p27, rabbit anti-gp85, or goat anti-RSV) 
diluted 1:20 in PBS+ 0.1% BSA was added to the monolayers and allowed 
to adsorb for 45 minutes at room temperature. The rabbit anti-p27 and 
anti-gp85 were generously provided by Dr. E. Hunter (University of 
Alabama Birmingham, Birmingham Al) and the goat anti-RSV was purchased 
from Microbiological Associate's, Bethesda Ma. The unbound antibody was 
removed by two one-minute washes in PBS + BSA and one 5 minute wash in 
the same buffer. Fifty ul of fluorescein-conjugated goat anti-rabbit 
IgG or rabbit anti-goat IgG (Antibodies Inc., Davis, Ca.) diluted 1:10 
in PBS + BSA was added and allowed to adsorb for 30 minutes at room 
temperature. The secondary antibody was removed by the same series of 
washed as described above. A cover slip was mounted on the monolayer 
with 50% glycerol in PBS + BSA. The staining was then visualized with 
an ultraviolet irradiation using a fluorescence microscope. 
Metabolic Labeling and Immunoprecipitation 
Viral specific products could be followed through the course of 
infection by radiolabeling newly synthesized proteins and then selec-
tively precipitating (Staph A) viral specific proteins with antisera 
raised against the individual proteins or the whole virus (Cullen and 
Schwartz, 1976). To follow the processing or degradation of the RSV 
proteins, transfected or infected monolayers were starved in medium 
lacking leucine and serum for one hour. The cells were pulse labeled 
with 200 uCi 3H-leucine (1 mCi/ml of 3H-leucine, New England Nuclear, 
Boston, Ma, in MEM without serum) for 15 minutes. Chases with un-
labeled leucine were performed in MEM + 3% fetal bovine and 6% calf 
bovine serum. 
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After radiolabeling the cells (60 mm plate), the medium was 
removed and the cells immediately lysed in 1 ml of lysis buffer 
without SDS (1.0% Triton X-100, 25 mM Tris-HC1, pH 8.0, 150 mM NaC1, 
and 1% deoxycholate). The monolayer was gently disrupted with a pas-
tuer pipet and transferred to a microcentrifuge tube. The nuclei were 
pelleted by centrifugation in a microcentrifuge (16,500g) for 5 
minutes. The lysate was removed and SDS was added to a final con-
centration of 0.1%. The lysates were then stored at -20°C. To assay 
for labeled proteins released into the cell culture fluid, the medium 
(0.8 ml) was removed and 1/5 volume (200 ul) of 5x lysis buffer con-
taining SDS (1 x recipe is the same as above but with 0.1% SDS). The 
samples were then processed the same as the above lysates. 
Twenty ul of a 1:10 dilution of primary antisera were added to 
0.5 
ml of radiolabeled lysate and allowed to adsorb overnight at 4°C. One 
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tenth ml of prepared Staph A (see below) which had previousl~ been 
determined to adsorb 95-99% of the IgG in 2 ul of the undiluted rabbit 
anti-p27 and anti-gp85 antisera preparations, were added to the 
lysates to precipitate the antibody-antigen complexes. After 30 
minutes, the Staph A-antibody-antigen complexes were pelleted for 10 
seconds in a microcentrifuge and washed twice in 500 ul of 1 x Lysis 
Buffer with SDS. The pellet was washed a third time in 20 mM Tris-HCl 
pH 7.5 to remove the salt and then suspended in 20 ul of dissociation 
buffer (see Appendix B). The sample was boiled for 1 minute to dis-
sociate the antigen and antibody from the Staph A. Irnmunoprecipitated 
proteins were then analyzed by SDS-PAGE (see below). 
To determine whether or not the gag precursor polypeptides were 
being processed in mammalian cells, it was of interest to increase the 
amount of protein being·synthesized in the transfected monolayers. 
Since expression of Pr76 could only be analyzed in transfected cells, 
the easiest way to increase the yield of Pr76 was to increase the num-
ber of cells being transfected. Also, since only transient expression 
was being analyzed, there was no need to cotransfect helper DNA. 
Therefore, 1 ug of vector DNA (fiSV.GAG or SV.KX) was transfected into 
nearly confluent CV-1 cell monolayers (60 rnm plate). After 48 hr. 
when maximal expression of the SV40 late region occurs, the medium 
was removed and the cells washed twice with prewarmed serum-free Dul-
beccos (MEM) lacking L-methionine (Gibco, Grand Island, N.Y.). The 
monolayers were then labeled with 70 uCi of TRAN35S-LABEL 
(ICN Biomedicals Inc., Costa Mesa, Ca.) in 0.8 ml. of the same serum-
free medium as above. After 30 minutes, L-methionine was added to one 
tenth the concentration of methionine in normal Dulbeccos MEM (final 
concentration of 1.2 x 10"4gjml). The cells were then labeled for an 
additional 2 hr at 37°C, 5% C02 to insure steady state levels of 
labeled protein and precursor processing. The labeling was then ter-
minated by placing the cells on ice. 
To determine if the gag antigens were released, the culture 
medium form the labeled cells was collected and any RSV gag specific 
antigens were concentrated by immunoprecipitation with an equal mix-
ture of goat anti-RSV (Prague strain): goat anti-RAV-0: goat anti-AMV 
p27 (Microbiological Associates, Bethesda, Md.) rabbit anti-goat IgG 
(Organon Teknika Co., West Chester, Pa.) and Staph A. For a negative 
control, the culture medium from SV.KX transfected monolayers was 
similarly collected and assayed for env proteins using the rabbit 
anti-gp85 antibody (Wills et al., 1984). 
To characterize the intracellular gag antigens, the same 
monolayers were gently lysed in the presence of phenylmethylsulfonyl 
floride and Pepstatin (1 x 10"3g/ml and 1 x 10"5g/ml respectively). 
The gag and env polypeptides were collected from half the lysates by 
immunoprecipitation using the same antibodies as used on the culture 
fluid. The precipitated proteins from both the lysates and culture 
fluid were separated on a 10% SDS polyacrylamide gel and analyzed by 
fluorography. 
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Preparation and Freezing of Staph. A. Ten ml of Brain Heart In-
fusion (BHI) medium (Difco Laboratories, Detroit, Mi.) was inoculated 
with Staphylococcus aureus Cowan 1 strain (ATCC #12598) and grown over-
night at 37°C with vigorous shaking. One liter of BHI broth was then 
inoculated with the 10 ml culture and incubated for 24 hr at 37°C. The 
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cells were harvested by centrifugation at 5000 rpm in a GSA type rotor 
for 10 minutes at 4°C; washed in 200 ml of PBS + 0.2% sodium azide pH 
7.2; pelleted again; and resuspended in 10% wjv PBS+ 1.5% formal-
dehyde. The cell suspension was then stirred at room temperature for 
90 minutes. After pelleting the cells again, they were resuspended in 
the same volume of PBS + 0.2% sodium azide and incubated at 80°C for 
2.5 to 5 minutes. The suspension was cooled immediately in ice and 
washed again in the same volume of PBS-sodium azide. The prepared 
Staph A was then stored at -80°C in 1 ml aliquots. 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Immunoprecipitated proteins were released from the Staph 
A-antibody complex by boiling for 1 minute in dissociation buffer (see 
Appendix D for SDS-PAGE recipes). These proteins were then separated 
on thin (1.5 mm) sodium dodecyl sulfate (SDS) acrylamide slab gels 
using the discontinuous buffer system described by Laemmli (1970) and 
Ames (1974). The standard resolving gel contained 10% acrylamide and 
NN'-methylene-bis-acrylamide at a ratio of 30:0.8 in 0.4 M Tris-HCl pH 
8.8 and 0.1% SDS. The polymerization of the acrylamide was initiated 
by the addition of ammonium persulfate and tetramethylethylenediamine 
(TEMED) to final concentration of 0.1 and 0.067% respectively. A 7mm 
stacking gel (1.5 mm thick) containing 3% acrylamide, 0.1% SDS, and 60 
mM Tris-HCl pH 6.8 was also polymerized with ammonium persulfate and 
TEMED. Twenty five ul of sample were loaded in each lane of a 14 x 16 
em gel and electrophoresed for 5 to 6 hr at a constant 0.134 mA\cm2 (30 
rnA). Gels were fixed and stained for 30 minutes at room temperature 
with Coomassie Brilliant Blue R250 (Sigma, St. Louis, Mo.) in 95% 
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ethanol; 5% acetic acid. The gels were destained overnight in 5% 
methanol:?% acetic acid. After destaining, the gels were prepared for 
fluorography according to the manufacturer's protocols. 
Fluoro~raphy. Destained gels were soaked for one hour in the 
autoradiography enhancer, "ENhance" (New England Nuclear, Boston Ma.). 
The organic enhancer was impregnated into the gels by soaking the gels 
for 30 minutes in water plus 5% glycerol. The gels were the dried 
onto Whatman 3 MM paper under vacuum using a slab gel drier (Hoeffer 
Scientific Instruments, San Francisco, Ca). The gels were usually 
dried for 1.5 hr at 60°C. The protein standards (see below) were 
marked with a small 5 ul drop of 14c ink. The dried gels were then 
placed on Kodak X-Omat AR film which was preflashed (Laskey and Mills, 
1975). The films were exposed at -80°C for 2 days to 2 weeks depending 
on the amount of labeled protein in the gels. Exposed films were 
developed according to manufacturer's protocols. 
Protein Molecular Wei~ht Determination. The molecular weight of 
the 3H-labeled protein bands were estimated by comparisons with the 
known electrophoretic mobilities of the protein standards (Low 
molecular weight standards, Bio-rad, Richmond, Ca.). The following 
proteins were used as standards: Phosphorylase B (97.4 kDa), Bovine 
Serum Albumin (66.2 kDa), Carbonic Anhydrase (31 kDa), Soybean Trypsin 
Inhibitor (21.5 kDa), and Lysozyme (14.4 kDa). The purchased low 
molecular weight standards were diluted to 100 ug/ml in Dissociation 
Buffer. Ten to twenty five ul was run as standards. 
PART I: 
EXPRESSION OF THE ROUS SARCOMA 




Expression of Pr76989 in Mammalian 
Cells By the Vector p~SV.GAG 
The SV40 late region replacement vector used in this study is 
capable of autonomously replicating its DNA in permissive cells since 
it contains an intact copy of the gene encoding the T Ag. This vector 
is not only capable of expressing the early genes, but the late genes 
as well. As mentioned earlier, the RSV gag gene has been subcloned 
into the late region of the SV40 genome in place of the SV40 coat 
proteins VPl, VP2, and VP3. This vector therefore can only be 
propagated by complementation by a helper virus providing the late 
proteins in trans (see Fig. 8). The helper virus, dll055, is an early 
deletion mutant the requires T Ag in trans for DNA replication. Com-
plementation between the two cotransfected DNAs in the same cell 
should result in the production of infectious virus; half of which 
should contain the vector DNA. The virus produced by these cells 
could then be used to infect virtually 100% of a fresh monolayer and 
induce cytopathic effects in 2-3 days. 
Intracellular Immunofluorescence 
To determine if the vectors, ~SV.GAG and SV.KX, were expressing 
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Figure 8. Schematic representation of cotransfecting 
CV-1 cells with vector (~SV.GAG) and helper (dll055) DNA. 
Complementation in trans between the vector and helper allows 
the production of infectious recombinant SV40 virions. This 
illustration of the cotransfection procedure was adopted from 
a figure provided by Dr. E. Hunter (University of Alabama 
Birmingham, Birmingham Al). 
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monol~yers were fixed with 95% ethanol, 5% acetic acid (voljvol) at 
various times post-transfection or post-infection. The permeable 
cells were then assayed for the respective RSV proteins by im-
munofluorescence using rabbit anti-viral antisera (either anti-p27 or 
anti-gp85) and fluorescein-conjugated goat anti-rabbit IgG (Antibodies 
Inc., Davis Ca). 
Photographs of typically stained cells at 45 hr post-
transfection are shown in Fig. 9. Both RSV gag and env products were 
detected and both display a staining pattern that is expected for each 
protein. The ~SV.GAG transfected cells show the gag product 
throughout the cytoplasm as a result of synthesis form cytoplasmic 
ribosomes. The SV.KX transfected cells show the env gene product lo-
calized around the nucleus resulting form synthesis on the RER No at-
tempts were made to quantitate the fluorescence intensities. Unlike 
that seen in SV.KX infected cells, intracellular fluorescence in 
6SV.GAG infected cells was rarely observed after the firs~ passage of 
the recombinant viruses and never observed after the second passage. 
Elucidation of the inability to propagate the vector was studied in 
detail and will be addressed in Chapter VI. However, since gag ex-
pression could not be analyzed in infected cells, the characterization 
of the gag antigens could only be studied in transfected cells. 
Metabolic Labelin~ and Immunoprecipitations 
To characterize the gag antigens expressed in CV-1 cells and to 
determine the optimal time of expression, nearly confluent monolayers 
(60 mm plates) were cotransfected with vector DNA (either SV.KX or 
Figure 9.A 
Figure. 9.B 
Figure 9. Intracellular immunofluorescence of CV-1 
cells cotransfected with helper and: 9.A, ~SV.GAG at 45 hr 
post-transfection, and 9.B, SV.KX at 45 hr post-transfection. 
The antibodies used to detect the antigens were a rabbit 
anti-p27 and rabbit anti-gp85 respectively. 
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~SV.GAG) and helper DNA. At various times post-transfection (15, 36, 
53, and 77 hr) the monolayers were labeled with 200 uCi [3H] leucine 
for 15 minutes and lysed. The gag specific antigens were collected by 
immunoprecipitation using the same antisera as above and separated by 
electrophoresis in a 10% SDS polyacrylamide gel. The labeled products 
were analyzed by fluorography. Figure 10 shows Pr76 to be the only 
gag protein immunoprecipitated with the anti-p27 antiserum (lanes 
1-4). The env precursor polypeptide, Pr95, was also the only peptide 
detected after the 15 min pulse (lanes 5-8). This figure also shows 
that maximum expression of both Pr76 and Pr95 occurs around 50 hr 
post-transfection. The dark bands at the bottom ant top of the gel 
are cellular proteins nonspecifically precipitated by the Staph A. 
To determine whether or not the gag precursor polypeptides were 
processed in mammalian cells, CV-1 cell monolayers were labeled, 48 hr 
after transfection,_ with TRAN35S-LABEL for 2.5 hr then lysed. Also, 
the cell culture fluid from the same monolayers were collected and 
both the cell lystes and culture fluids were assyaed for the presence 
of gag or env antigens by immunoprecipitations and 10% SDS-
polyacrylamide gel electrophoresis. One such fluorogram is shown in 
Figure 11. 
After 2.5 hr, labeled Pr95env could easily be detected in the 
cell lysate and the larger of the two processed forms of Pr95, gp85, 
was barely detectable (Fig. ll.A, lane 1). The slight appearance of 
gp85 at 2.5 hr is consistent with observation that 50% of Pr95 is 
processed 2 to 3 hr after pulse-labeling CV-1 cells (Wills et al., 
1984). Also consistent with Wills et al. (1984) is that nether Pr97 
nor gp85 is released into the culture fluid (Fig. ll.B, lane 1). The 
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Figure 10 . Characterization of the polypeptides im-
munoprecipitated from CV-1 cells transfected with the recom-
binant gag and env vectors. Cotransfected cells were pulse-
labeled at various times after transfection and lysed. 
Samples of the lysates were separated by 10% SDS-PAGE and 
visualized by fluorography. The lanes are defined as fol-
lows: M, low molecular weight standards; (lanes 1-4, ~SV . GAG 
cotransfected cell; lanes 5-8, SV.KX cotransfected cells) 
lanes 1 and 5, 15 hr; lanes 2 and 6, 36 hr; lanes 3 and 7, 53 
hr; and lanes 4 and 8, 77 hr post - transfection. 
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Figure 11. Steady state labeling of transfected cells 
with TRAN35s-LABEL. CV-1 cells transfected with 1 ug vector 
DNA only were labeled with [35s] methionine at 48 hr post-
transfection and lysed. Immunoprecipitates were analyzed by 
10% SDS-PAGE and fluorography . Samples from the lysates are 
shown in Panel A, medium in Panel B. The lanes are defined 
as follows: lane 1, SV.KX, M low molecular weight standards; 
lane 2, uninfected; lane 3, SV.p27 , and lane 4, aSV.GAG 
transfected CV-1 cells. 
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band at the top of all the lanes represents fibronectin or some other 
host protein nonspecifically precipitated by Staph A. Lane 2 in both 
panels depicts the protein profile from the lysates and cell culture 
fliuds from uninfected cells processed in the same manner as all the 
transfected monolayers and immunoprecipitated with the goat anti-RSV . 
antibody mixture. Likewise, lane 3 in both panels depicts the profile 
of lysstes and culture fluids of CV-1 cells transfected with 120 ng of 
an SV40 vector carrying the RSV p27 coding sequence only and 36 ng of 
helper DNA and immunoprecipitated with the same goat antibody mixture. 
These lanes help to identify those proteins specific to the trans-
fected cells. The construction of the SV.p27 vector was described 
earlier. There is a faint band present in panel A, lane 3 (arrow) 
that has an electrophoretic mobility of approximately 32-33 kDa. This 
band was visible after longer exposure and may represent a protein in-
itiating at the SV40 agno AUG and terminating dounstream of the p27 
coding sequence since it is recognized by the anti-p27 antisera. If 
this product is a modified p27 product, it has a very short half life 
when expressed form this vector in CV-1 cells since the amount of 
protein present is very low. 
Lane 4 in both panels depicts those proteins immunoprecipitated 
with the goat anti-RSV mixture fromASV.GAG transfected cells. A dif-
fuse band which migrated with a mobility characteristic of a 76kDa 
polypeptide was detected. There were also a number of smaller 
proteins detected that ranged in size form 27kDa to 69 kDa. Com-
parison of this profile to those of uninfected, transfections (using 
different vectors ie. SV.KX and SV.p27), or nsV.GAG transfected cells 
pulse labeled for 15 minutes (see Figure 10), demonstrated the 76, 68, 
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28, and 27 kDa bands (arrow heads ) to be unique to CV-1 cells trans-
fected with 1 ug of ~SV.GAG DNA. Lane 4, panel B, clearly shows that 
no RSV gag. specific proteins were released into the cell culture 
fluid. 
Inability to Propagate ~SV.GAG 
Although we were able to successfully express Pr76 in trans-
fected cells, repeated attempts to detect the gag antigens in infected 
monolayers failed. This is in contrast to SV.KX which continued to 
express env antigens after three serial passages. (Wills et al., 
1984). Because the total size of asV.GAG is slightly larger than the 
wild-type SV40 genome (100.5%), we ini~ially attributed the inability 
to propagate ~SV.GAG to a size packaging limitation. To test this 
hypothesis, we introduced 3'-end deletions into the gag coding region 
with the double-stranded specific Bal 31 exonuclease. Three clones 
were chosen for further analysis and the extent of each deletion was 
estimated by restriction analysis. The end points of these deletions 
are shown in Figure 7 (black arrows). These clones are approximately 
82%, 88%, and 96% of the size of the wild-type SV40 genome. 
To determine the effect of these deletions on the ability to 
propagate the mutant vectors, the vector DNAs were cotransfected with 
helper DNA into nearly confluent monolayers as previously described. 
The amount and type of SV40 DNA present in the transfected monolayers 
7-days post-transfection was determined by extracting the circular DNA 
according to the method of Hirt (1967). As shown in Figure 12, SV.KX 
was the only vector capable of propagating in the transfected 
monolayers (lane 7). The major 3 kb band was determined to consist of 
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both SV.KX and helper (dll055) DNA by restriction analysis (data not 
shown). The inability to propagate ~SV.GAG or any of the BAl 31 dele-
tion mutants was repeatedly observed after numerous transfections 
(over 60). 
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Figure 12. Samples of Hirt extracts from cells 
cotransfected with 3'-end deletions in gag which were created 
with the exonuclease Bal 31. Samples were taken seven days 
post-transfection. Lane 1) Smallest gag deletion (96% of the 
size of SV40; lane 2) medium gag deletion (88%); lane 3) 
smallest gag deletion (82%); lane 4) Marker DNA; lane 5) un-
transfected cells; lane 6) ~SV.GAG tranfected cells; 7) SV.KX 
transfected cells. Chromosomal (Chm'l) and covalently closed 
circular (ccc) DNA are indicated. 
To evaluate the possibility that Pr76 might be toxic to the 
transfected cells and therefore inhibit propagation, a +1 frameshift 
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was introduced at a unique Xho I (nucleotide position 630 in RSV) in 
the pl9 coding region (see Fig. 7). The pASV.GAG DNA was linearized 
with Xho I and blunt ended with the Klenow fragment of E. coli 
polymerase and dNTPs. The DNA was circularized by blunt-end ligation 
(which creates a new Pvu I site) and transformed in to E. coli DH-1 
cells (see Material and Methods). Transformants were picked and the 
plasmids were screened for the loss of the Xho I site and the creation 
of a new Pvu I site (data not shown). The 4 bp insertion should 
eliminate expression of all Pr76 except for about 50% of pl9. 
We tested the stability of this mutant in the SV40 vector by 
cotransfection and subsequent DNA extraction 7 days post-transfection. 
Figure 13 shows that mutants defective for Pr76 synthesis are also un-
stable in CV-1 cells and gave rise to wild-type SV40 after 8 to 10 
days (data not shown). 
The possibility that the "toxicity" might be due to a truncated 
pl9 product in the frameshift mutants was examined. Also, the RSV 
splice donor site in pl9 might allow aberrantly spliced 
messages that could code for products toxic to the CV-1 cells or in-
hibit SV40 replication. The 5' region of gag which contains the Pr76 
AUG start codon was therefore deleted by removing the Kpn I-Xho I 
fragment of pASV.GAG. This 427 bp fragment was removed by digesting 
with Kpn I and Xho I. The remaining 8600 bp fragment was gel purified 
and circularized by blunt-end ligations with the E.coli Klenow frag-
ment, dNTPs, Polymerase I and ligase and ATP (see Material and 
Methods). Three positive clones were choosen and tested for their 
ability to be propagated previously described. 





Figure 13. Recombinant SV40 vector DNA carrying a +1 
frameshift mutation near the 5' terminus of the gag gene were 
cotransfected along with helper DNA into CV-1 cells and seven 
days later, Hirt extracts were obtained. Samples of these 
DNAs were analyzed by agarose gel electrophoresis to deter-
mine if the vectors had replicated. The lanes are defined 
as: 1) untransfected cells; 2) Frameshift mutation of 
tSV.GAG; 3) Frameshift mutation of the largest gag Bal 31 
mutant clone #1; 4) frameshift mutation of large Bal 31 
mutant clone #2; M) Lambda DNA digested with Hind III 
(standards); 5) frameshift mutation of smallest Bal 31 




Hirt extractions were performed 9 days post-transfection. Since 
the efficiency of transfections is low and varies with the confluency 
of the monolayer and other not well defined parameters, the time at 
which the monolayers are sacrificed was based on SV.KX's ability to 
induce major cytopathic effects. Figure 14 shows that the mutant vee-
tors were unstable in CV-1 cells (lanes 5-7) and only SV.KX (lane 2) 
was able to replicate. The faint 3 kb band in lanes 1, 5, 6, and 7 
was determined by restriction analysis to be wild-type SV40 DNA that 
probably arose from homologous recombination between the vector and 





Figure 14. Hirt extracts of CV-1 cells cotransfected 
with the 5'-end deletions . Samples were taken nine days 
post-transfection. Lanes are as follows: 1) ~SV.GAG; 2) 
SV.KX; 3) untransfected cells 4) marker DNA; 5) 5'-end dele-
tion #1; 6) 5'-end deletion #2; 7) 5'-end deletion #3. 
CHAPTER V 
DISCUSSION 
Von der Helm et al. (1980) and Vogt et al. (1982) demonstrated 
that RSV infected mammalian cells expressed very low levels of the RSV 
"particle making machinery," Pr76989 , and failed to process the precur-
sor molecules into the mature structural proteins. To determine 
whether or not the block to replication of RSV in mammalian cells is 
actually due to insufficient levels of transcription or translation of 
Pr76, the SV40 late region replacement vector was chosen to express 
the RSV gag gene in a transient expression system in order to increase 
the levels of Pr76 in mammalian cells. If increased expression of 
Pr76 results in precursor processing, it would suggest that specific 
avian products or avian protein sorting signals are not required for 
correct targeting of the precursor molecules to the site of assembly. 
It would also suggest that elevated concentrations of Pr76 are essen-
tial for the intermolecular interactions needed for processing. The 
results in Chapter IV demonstrated the usefulness of the SV40 late 
region replacement vector in expressing elevated levels of Pr76 989 in 
mammalian cells. 
Protein Characterization 
It has been demonstrated that CV-1 cells, cotransfected with 
either ~SV.GAG or SV.KX and helper DNA, were capable of expressing 
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high levels of the respective gag or env antigens when assessed by 
intracellular immunofluorescence. The staining pattern in~SV.GAG­
helper cotransfected cells, shown in Figure 9.A, is consistent with 
the observations that Pr76989 is synthesized on cytoplasmic ribosomes 
(Lee et al., 1979 and Purichio et al., 1980). Similarly, the pattern 
in the SV.KX-helper cotransfected cells shows Pr95env (or gp85) local-
ized around the nucleus. Wills et al. (1984) determined that this 
"halo" was actually env polypeptides in the rough endoplasmic 
reticulum and the continuous nuclear membrane. 
The immunofluorescence also showed numerous cells which were not 
transfected. Those transfected cells which were labeled with the 
fluorescein conjugated antisera, are much larger than the uninfected 
cells and have an enlarged nucleus typical of SV40 infected cells 
(Martin, 1981). 
The antigens recognized in the transfected cells by the an-
tiviral antibodies were determined by immunoprecipitation of the cell 
lysates which had been ·pulse-labeled for 15 minutes. It was 
demonstrated that the major antigens selectively precipitated were 
either Pr76989 or Pr95env. The appearance of only the precursor 
products was expected since processing is known to occur post-
translationally. Since it was repeatedly observed that the gag an-
tigens could not be detected in infected monolayers, precursor 
processing could only be determined by transient expression in the 
transfected monolayers. To achieve steady state protein labeling 
needed for the characterizations, monolayers, labeled for 2.5 hr were 
transfected with eight times as much vector DNA as normally used and 
no helper DNA was added. Figure 11 showed that Pr95env was easily 
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detected in SV.~ transfected monolayers whereas gp85 was only 
slightly visible on the autoradiogram. These results are consistent 
with Wills et al. (1984) who demonstrated that Pr95 processing begins 
around 2.5 to 3 hr post-infection. It can be concluded then that the 
expression system was working correctly 
The protein profile observed after ~SV.GAG transfection 
demonstrated that the majority of the antigens present in the 6SV.GAG 
transfected monolayers was in the precursor form. It was observed 
however that a few bands were present in these profiles which had not 
been previously reported in mammalian cells expressing the RSV gag 
products when protease inhibitors were added to the lysis buffer. 
These three bands with estimated molecular weights of 27, 28, and 68 
kDa are unique to the ~SV.GAG transfected cells and may represent 
authentic precursor processing (albeit very inefficient). 
Even though Pr76 processing was observed in mammalian cells, it 
is not clear why it was .such an inefficent processing it would be ex-
pected that all the precursor would act in a simialar manner. The 
results presented here suggest that only a small portion of the 
molecules are capable of being processed. A possible explanation for 
these results might be that the 76 kDa band observed in the im-
munoprecipitates of the pulse labeled cells (Figure 10) was not 
homogeneous population. In fact, the predicted nucleotide sequence of 
the vector reveals two start codons upstream of the gag start codon. 
The first AUG, which is used to initiate translation of the SV40 agno 
protein, lies in a good initiation context according to Kozak (1986) 
and lies 142 bp upstream of and out of frame with the gag start codon. 
Initiation at this codon would cause the ribosomes to bypass the gag 
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AUG codon and probably terminate just down stream of the Pr76 AUG 
codon at any of the stop codons in frame with the agno AUG. This 
however does not explain the possible heterogenity. If this proposed 
event did occur and the ribosomes were able to reinitiate, ribosomes 
might be able to reinitiate translation at the next AUG codon. This 
second start codon lies 28 codons downstream of and in frame with 
authentic Pr76 AUG codon. Reinitiation at this codon would result in 
a polypeptide 28 amino acid shorter than the full length Pr76 
molecule. This truncated precursor might possibly share similar an-
tigenic determinants of Pr76 thus its presence in the im-
munoprecipitates. If the important control signals for targeting or 
processing are located at or near the amino terminus of the precursor 
molecule, the truncated protein would not be expected to be processed 
or released from the transfected cells. 
Assuming an average of 100 daltons per amino acid, the truncated 
product should be approxi~ately 2.5 to 3 kDa smaller than the full 
length precursor molecule. Figure 10 in fact revealed a very faint 
band just slightly higher than the labeled 76 Kda band. This larger 
product may represent the full length precursor molecule and the 
smaller may represent the truncated form. The reason the smaller band 
is more pronounced may be explained by Kozak's rules which, based on 
the context of the sequences surrounding the different AUG codons, 
suggest the agno start codon would be used more often than the Pr76 
start codon. 
Initiation at the second codon upstream of the gag AUG would not 
be expected to result in a truncated precursor molecule since there is 
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an in frame stop codon upstream of the gag AUG. However, initiation 
at this upstream AUG would further results in diminished tranlsation 
initiation at the authentic gag AUG codon. 
The results shown in Figures 10 and 11 are inconsistent with 
those reported by Vogt et al. (1982). They reported that only the 
precursor form of the gag proteins was present in several mammalian 
cell lines transformed with RSV. They suggested that in.those mam-
malian cell lines where the gag precursor seemed to be autocatalyti-
cally processed (Fleissner, 1970 and Ghysdael et al., 1977), process-
ing was actually due to nonspecific protein degradation that occurred 
immediately upon cell lysis. They demonstrated that they could in-
hibit this nonspecific or host regulated processing by the addition of 
the sulfhydryl-blocking reagent N-ethylmaleimide (NEM). It is un-
likely that the smaller molecular weight proteins observed resulted 
from nonspecific protein degr~dation since the cells were lysed in the 
presence of the protease inhibitors phenylmethylsulfonyl fluoride and 
pepstatin. Also, if the processing observed in Figure 11 was due to 
nonspecific degradation, the same break down products should have been 
observed in Figure 10. However, nonspecific degradation can not be 
ruled out since NEM was not included. 
There are a couple of explanations as to why processing has 
never been reported in most mammalian cells since Chapter IV estab-
lished that processing can occur (albeit very inefficiently) in mam-
malian cells upon increased expression of Pr76989 • In all of the 
reports to date which suggest that processing does not occur in mam-
malian cells, the investigators were studying RSV transformed cells 
which had been shown to express very low levels of Pr76. Therefore, 
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the only way to even detect Pr76 in mammalian cells would be to in-
crease the actual number of transformed cells being assayed and use 
more sensitive detection methods like western blotting. Since 
processing is such an inefficient event in mammalian cells, merely in-
creasing the amount of Pr76 to just detectable levels would not reveal 
the processed intermediates or the final products. Another explaina-
tion is that some inherent intracellular concentration of Pr76 is re-
quired for processing and is not obtained in RSV infected mammalian 
due to inefficient expression. 
Since processing is a rare event in RSV transformed mammalian 
cells but can be induced upon increase expression, there must be some 
type of processing signal or pathway specific for avian cells that 
differs from that in mammalian cells. One such possible signal 
present in only the mammalian retroviruses may be the addition of a 
myristic acid to a glycine residue at amino acid position number two. 
In fact this addition is essential for Moloney murine leukemia virus 
precursor processing and particle formation (Rein et al., 1986). 
Even though it has been shown that Pr76 can be processed (albeit 
inefficently), it can not be determined from these experiments whether 
or not gag specific products were released from transfected mammalian 
cells. The gag products (full length Pr76 or processed forms) might 
have been release but have escaped detection by metabolic labeling and 
immunoprecipitation. Likewise, previous reports (Volker et al., 1982) 
which showed that neither RSV gag specific antigens nor virus par-
ticles are capable of being released from RSV transformed mammalian 
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cells should be reconsidered since low levels of Pr76 expression in 
transformed cells would not give rise to detectable levels of antigens 
or reverse transcriptase activity in the cell culture fluids. 
According to one model, the apparent inability of Pr76 to be 
correctly processed in mammalian cells is a result of an inability to 
correctly assemble virus particles (a prerequisite to processing). 
Another model suggest that processing is a prerequisite to budding. 
Therefore the block to particle formation in mammalian cells is due to 
an inhibition of precursor processing (Dickson et al. ,1982). A third 
model suggests that cleavage of Pr76 can only occur in the final 
stages of, or subsequent to, the budding of virus particles from the 
plasma membrane. Thus, if P~76 were unable to interact with the 
plasma membrane correctly, then it might not be able to achieve the 
right conformation required for processing and subsequently budding 
(Vogt et al., 1982). The results presented here suggest that the 
later model is probably more correct but not entirely true. Our 
results suggest that a subpopulation of Pr76 molecules (ones that are 
full length) are capable of being processed in mammalian cells. These 
results however can not distinguish between either processing or bud-
ding being a prerequisite to the other. One plausible explanation is 
that myristic acid addition is required to achieve the correct confor-
mation required for budding or processing since mammalian retroviruses 
which are not modified act just like Pr76 in mammalian cells (Schultz 
and Oroszlan, 1983 and Rein et al., 1986). Although these results are 
highly suggestive of precursor processing, more detailed experiments 
are required to demontrate that the lower molecular weight polypep-
tides are authentic processed gag proteins. 
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Inability to Propagate ASV.GAG 
Although we were able to successfully express Pr76 at high 
levels in mammalian cells upon transfection, we were unable to 
propagate the vector on fresh monolayers. Our first hypothesis was, 
since the size of the vector genomes was 100.5% of that of the wild-
type SV40 genome, the vector was incapable of being packaged to due a 
size constraint. We therefore created a series of end-point deletion 
mutations that ranged from 82% to 96% of the SV40 genome. These dele-
tion mutants were also unstable in the transfected monolayers. 
Another possibility was that the RSV gag products were either 
lethal to the mammalian cells or to the SV40 replicative strategy. To 
test this hypothesis, two different mutations were created that 
abolish Pr76 synthesis. The first mutation was created by introducing 
a +1 frameshift at a unique Xho I site located in the middle of the 
pl9 coding region. This construction, confirmed by restriction 
analysis, was shown to be just as unstable as ~SV.GAG in the trans-
fected monolayers. 
This altered vector might be making a detrimental product such 
as a truncated pl9 peptide or some other protein arising from an 
spliced message since the splice donor site is still intact. We 
therefore constructed another vector in which the Kpn I-Xho I fragment 
was removed. This vector should be unable to synthesize any gag re-
lated product since the SV40 agno and Pr76 start codons were removed. 
This vector should also be unable to transcribe any mRNAs from this 
region since the SV40 late promoter ha been altered. This construc-
tion however was also unstable in the SV40 vector. We therefore con-
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elude that the inability to propagate the ~SV.GAG vector lies at 
either the DNA or RNA level since other constructions (SV.KX) which do 
not contain the gag sequences are fully capable of being propagated in 
CV-1 cells. This inability to propagate the ~SV.GAG vector was 
studied in detail and is addressed in Part II of this thesis. 
PART II. 
ELUCIDATING THE CAUSE OF THE 
BLOCK T06SV.GAG REPLICATION 
CHAPTER VI 
RESULTS 
Elucidating the block to .C.SV.GAG Propagation 
Time Course Hirt Extraction 
As shown in Part I, neither i..\SV .GAG nor helper (dll055) DNA 
could be detected in CV-1 cells 5 to 7 days post-transfections when 
Hirt extracts were analyzed on ethidium-bromide stained agarose gels. 
This could be accounted for by a number of explanations. If the ef-
ficiency of packaging was low, the DNA would be lost after a couple of 
rounds of virus replication in the transfected monolayers. As a con-
sequence, the helper DNA would also be lost due to a lack of T Ag. To 
test this hypothesis, cotransfected monolayers were sacrificed at 
various times post-transfection (25, 62, 104, and 177 hr) and the SV40 
DNA was purified by Hirt extractions in an attempt to find the time at 
which the recombinant SV40 DNA was lost in the monolayers. 
Figure 15 shows that neither i::..SV. GAG nor dll055 DNA could be 
detected on ethidium-bromide stained agarose gels at any time post-
transfection (gel A, lanes 1-4). In contrast, gel B shows that both 
SV.KX and dll055 DNAs replicated in the monolayers and was detectable 
by 62 hr (gel B, lane 2). The amount of DNA in the monolayers greatly 
increased by 104 hr. By 177 hr, the time at which the greatest 
cytopathic effects were observed, the amount of DNA present in the 
monolayers reached its maximum. Hirt extracts at longer times 
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after transfection generally yield lower amounts of DNA since the 
monolayers were completely destroyed by the infection. The time of 
vector DNA replication (after 28 hr) in transfected cells is consis-
tent with that observed with infected cells (gel A lanes 5-7). 
COS-1 Cell Cotransfections 
The above experiments suggest that the inability to propagate 
the gag vectors is due to an inability to assemble recombinant SV40 
virus since no SV40 DNA (vector or helper) was detected even after one 
or two rounds of viral replication unlike SV.KX which was detectable 
by 62 hr. Another possible explanation for this inability to 
propagate SV40-gag vectors might be that the insertion of the gag 
coding region, which contains a directional enhancer (Arrigo et al., 
1987) into .the SV40 genome alters T Ag expression and subsequently al-
ters DNA replication and late gene expression. In order to eliminate 
this possibility, vector DNAs were cotransfected into COS-1 cells, a 
cell line constitutive for T Ag expression. T Ag expression in these 
cells was confirmed by intracellular immunofluorescence using a 
monoclonal antibody against the T Ag expression and subsequently al-
ters DNA replication and late gene expression. In order to eliminate 
this possiblity, vector DNAs were cotransfected into COS-1 cells, a 
cell line constitutive forT Ag (data not shown). 
Transfected COS-1 cell monolayers were sacrificed and assayed 
for SV40 DNA after 4 and 7 days. Figure 16.A, which represents 5% of 
the extract, shows a prominent band of about equal intensity in both 
the ~SV.GAG and SV.KX cotransfected samples at both 100 and 170 hr 
(lanes 1, 2, 4, and 5). 
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Figure 15. Time course Hirt extracts. CV-1 cells were 
either cotransfected with ASV.GAG or SV.KX and helper DNA or 
infected with SV.KX. Cells were lysed and SV40 DNA was ex-
tracted. Panel A, lanes 1-4, bSV.GAG transfected cells, 
lanes S-7, SV.KX infected cells, Pabel B lanes 1-4, SV.KX 
transfected cells. Lanes 1 (both Panel A and B), cells lysed 
after 25 hr; lanes 2, cells lysed after 62 hr; lanes 3, cells 
lysed after 104 hr;, lanes 4, cells lysed after 177 hr . 
Lanes 5-7 (Panel B) are extracts from cells infected with 




Figure 16. Hirt extracts from cotransfected COS-1 
cells. To test the ability of the recombiant vectors to 
replicate with constitutive T-Ag expression, COS-1 cells were 
cotransfected and lysed at various times. Panel A depicts 
samples from Hirt extracts of ~SV.GAG cotransfected cells 
after 4 days (lane 1) and 7 days (lane 2) and SV.KX 
cotransfected cells after 4 days (lane 4) and 7 days (lane 
5). Panel B demonstrates the type of DNA present in the 
samples in Panel A. The same amount of sample was subjected 
to restriction enzyme digestion (see text for specific en-
zymes used) to separate the helper DNA from the vector and 
insert DNA. Again lanes 1 and 2 are samples from ASV.GAG 
tranfected cells at 4 and 7 days post-transfection and lanes 
45 are samples from SV.KX transfected cells at 4 and 7 days 
post-transfection respectively. "H" is helper (dll055) DNA. 




The type of DNA present in these Hirt extracts was determined by 
digesting 5% of the extract with Kpn I and Xba I. This double digest 
only linearizes the helper DNA (5000 bp) and releases the RSV gag se-
quences (2528 bp) or env sequences (1800 bp) from the vector (3000 
bp). Figure 16.B shows that only one 5000 bp band was present in the 
~SV.GAG-helper extracts (lanes 1 and 2). In contrast, lanes 4 and 5 
show that all three sequences (helper, vector and env) are present. 
Lane 3 (uninfected) again shows that these bands are unique to the 
transfected cell extracts. The possibility remains that the linear 
band present in lanes 1 and 2 might be wild type SV40 DNA that arose 
from homologous recombinantion between the vector and helper DNA 
molecules. However, it is unlikely since wild type SV40 was never 
detected in this system after only four days especially at these in-
tensities. 
Characteriz'ation of the Vector's 
Replication Cycle 
In order to determine whether or not the recently described 
directional enhancer element located in the plO coding region of the 
RSV gag gene or some other element in b. SV. GAG might be interfering 
with the SV40 replicative strategy and thus inhibiting vector replica-
tion, the replicative cycle (DNA replication and late gene expression) 
of tSV.GAG was characterized. One way to assess early gene expression 
was to determine the timing of vector DNA replication since SV40 DNA 
replication is dependent upon TAg (Freid and Prives, 1986). 
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Vector DNA Replication. Since it has already been established 
that the vector 6SV.GAG is not capable of producing infectious progeny 
virions, it was of interest to determine whether or not the vector DNA 
was replicating in those cells which were actually transfected. If 
so, it was important to characterize the timing of DNA replication to 
assess any alterations in the timing of SV40 DNA replication invoked 
by the vector sequences. However, since only very few of the cells in 
a monolayer are capable of being transfected, DNA replication could 
only be addressed by Southern hybridizations. This technique also al-
lows differentiation of helper DNA from vector DNA by hybridizations 
to specific probes. The probe used to differentiate between the hel-
per genome and the ~SV.GAG genome was the plasmid pAT.p27 which con-
tains the plasmid pJC-2 and the RSV p27 coding region. The construe-· 
tion of this plasmid was described earlier. The helper sequences as 
well as the vector and env sequences were detected by hybridizati~ns 
to the [32P]-labeled plasmid pSV.KX. 
In order to discern whether or not the transfected DNAs were 
replicating, a series of nearly confluent CV-1 cell monolayers (60 mm 
plates) were cotransfected with either ~SV.GAG or SV.KX and dll005 
DNA. Any extracellular DNA remaining after the 4 hr chloroquine 
treatment was degraded by washing the monolayers twice in PBS and then 
incubating the cells in serum-free Dulbecco's MEM containing 50 ug/ml 
DNase I for 1 hr at 37°C. The DNAse I was removed by washing the 
monolayers twice in PBS. The monolayers were then further incubated 
in growth medium for 15, 27, 40, or 50.5 hr. At the time of sampling, 
the monolayers were sacrificed and SV40 DNA was purified by Hirt ex-
tractions. Eight percent of each extract was run on two 0.8% 
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Agarose gels containing 0.5 ug/ml ethidium-bromide. The DNA was 
transferred to nitrocellulose filters by the method of Southern 
(1975). One filter was hybridized to 32P-nick translated pAT.p27 
(approx. 22 uCi). The second filter was hybridized to the 32P-nick 
translated pSV.KX (approx. 33 uCi). The DNA was allowed to hybridize 
for 24 hr at 42°C in the presence of 45% fromamide and then washed un-
der high stringency conditions. 
Figure 17 shows the autoradiogram of both hybridizations. Gel A 
was probed with pAT.p27 and Gel B was probed with pSV.KX. The inten-
sities of the bands on both autoradiograms were measured by den-
sitometric scanning at 633 nm. The results of the scans are shown in 
Figure 18. These figures demonstrate both ASV.GAG and SV.KX DNAs 
begin to replicate around 30 hr post-transfection. The amount of DNA 
dramatically increases by 40 hr. SV.KX DNA (and helper DNA) continued 
to exponentially increase by 50.5 hr due to its ability to infect the 
whole monolayer. The amount of ASV.GAG and helper DNA however began 
to decrease after 40 hr due to degradation and an inability to produce 
infectious particles. The two bands in Gel A (Fig. 17) lanes 7 and 8 
are either the pSV.KX plasmid DNA replicating in the CV-1 cells due to 
T Ag and the SV40 origin of replication or dimers of the circular vec-
tor DNA. 
The type of DNA present in these Hirt extracts was determined by 
digesting the extracts with Kpn I and Xba I. This double digestion 
linearizes the helper DNA (5200 bp) and releases the SV40 vector se-
quences (3000 bp) from the gag (2528 bp) or env sequences (1800 bp). 
The DNAs were separated on 0.8% Agarose gels and hybridized to the 
same two probes. Figure 19 shows that all three sequences (helper, 
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Figure 17. Vector DNA replication assessed by Southern 
hybridization of Hirt extracts. Vector DNA replication was 
determined by extracting SV40 from CV-1 cells that had been 
cotransfected with vector and helper DNA 15, 27, 40 and 50.5 
hr before. The DNA was separated by agarose gel 
electro~horesis and Southern blotted to nitrocellulose fil-
ters. 2P-Nick translated probes (either pAT.p27 or pSV.KX) 
were then allowed to hybridize for 24 hr at 42°C in the 
presence of formamide. The filters were then washed under 
high stringency conitions before autoradiography. Panel A 
depicts samples probed with pAT.p27 which detects p27 se-
quences only. Lanes 1-4 are samples fromASV.GAG 
cotransfected cell at 15, 27, 40, and 50.5 hr post-
transfection. Lanes 5-8 are samples from SV.KX transfected 
cells taken at the same time (15, 27, 40, and 50.5 hr respec-
tively) post-transfection. Panel B demonstrates SV40 and env 
sequences present in the same samples as those in panel A. 
Lanes a-d are from the same extracts as lanes 1-4. Lanes e-h 
are indentical samples as those in lanes S-8. 
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Figure 18. Results from a densitometric scan of the 
autoradiogram in Figure 17. The plots represent the band in-
tensities of the autoradiogram (aborabance at 633 nm x width 
of the band) -vs- time after transfection The top scan rep-
resents ths scan of Fiter A. The time of ~SV.GAG DNA 
replication is shown by (-x-). SV.KX replication (-6-). The 
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Figure 19 . Determination of the type of DNA present in 
the extracts from Fig 17, The same samples were digested 
with restriction enzymes to linearize the helper genome and 
release the vector sequences from either the gag or env se-
quences . After agarose gel electrophoresis, the DNAs were 
transfered to nitrocellulose and probed with the same probes 
in Figure 17. The top gel is the ethidium stained gel of the 
autoradiograms below. Lanes 1-4 are samples from SV . KX 
cotransfected cells after 15, 27, 40, and 50 . 5 hr . Lanes 5-6 
are samples from~SV.GAG cotransfected cells after 15, 27, 
40, and 50.5 hr respectively. "h" designates helper sequnces 
whereas "v" designates the vector sequences. 
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vector, and env) from the SV.KX transfections were detected at 27 hr 
when probed with pSV.KX (Gel A, lane 2). Both helper and vector se-
quences were also detected at 27 hr inASV.GAG extracts. The gag se-
quences were also detected at 27 hr when probed with pAT.p27 (Gel B). 
The 3:1 ratio of the amount of vector DNA to helper DNA initially 
cotransfected was still observed after densitometric scanning of the 
autoradiogram in Fig. 19, confirming that both vector and helper DNAs 
were equally replicated (data not shown). These result suggest that, 
at the DNA level, neither the vector nor the helper DNA had a selec-
table advantage to replicate in CV-1 cells 
Time-Course Immunofluorescent Assays. Since it has been 
demonstrated that the ~SV.GAG DNA replicates in the transfected cells, 
the possibility existed that the timing of late gene expression is al-
tered. To determine this, cotransfected cells were fixed for 
intracellular staining as previously described at various times post-
transfection (23, 35, and 45 hr). Figure 20 demonstrates that Pr76 
synthesis begins between 23 and 35 hr post~transfection. SV.KX 
cotransfected cells showed similar times of expression of Pr95env (data 
not shown). 
Time-Course Pulse Labeling. To further demonstrate the timing 
of Pr76 and Pr95 synthesis, cotransfected monolayers were pulsed 
labeled for 15 minutes with [3H] leucine at 15, 36, 53, and 77 hr 
post-transfection and then lysed. Immunoprecipitates (using the same 
antisera as above) were separated on 10% SDS polyacrylamide gels and 
the radiolabeled products were visualized by fluorography. The 
fluorogram (see Fig. 10) was then analyzed by densitometric scanning 
Figure 20. Intracellular immunofluorescence of CV-1 
cells cotransfected with ~SV.GAG after 23 hr (top), 35 hr 
(middle), and 45 hr (bottom). 
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at 633 nm using the LKB Ultrascan XL Laser Densitometer. Figure 21 
shows SV40 late gene expression of both Pr76 and Pr95 begins prior to 
36 hr post-transfection. Maximal expression for both polyproteins oc-
curred around 50 hr and by 77 hr, the levels of expression had 
decrease probably marking the end of viral replication. The dif-
ference in the amount of protein between SV.KX and /:..SV.GAG can be ex-
plained by possible differences in translational efficiencies and 
protein half-lives (see Part I). 
DNAse I Protection. Since the inability to propagate bSV.GAG 
did not lie at the protein level nor was it due to insufficient DNA 
replication or altered gene expression, we tested the ability of the 
i:..SV. GAG DNA to be packaged into DNase I resistant SV40 particles. It 
the vector DNA was incapable of being packaged into virions, but the 
helper was, only the helper DNA should be protected from DNase I. 
Figure 22 shows the autoradiogram of a Southern hybridization in 
which the ability of the vector and helper DNA to be packaged into 
DNase I resistant virions was tested (see Materials and Methods). 
Lanes 1 through 4 are samples from a monolayer infected with SV.KX and 
dllOSS virions at 84 hr post-infection. Lane 1 shows the untreated 
extract. THe helper DNA (5000 bp) was detected as well as the vector 
(3000 bp) and env (1800 bp) sequences. Lane 2 which only had plasmid 
DNA added shows the same bands as in lane 1 except for new band 
(linearized pUC19) between the SV40 and env sequences. Lane 3 which 
had both plasmid DNA and DNase I indicates that the plasmid DNA was 
susceptible to DNase I while the helper, vector, and env sequences 
were resistant. Also the smear of chromosomal DNA that was present in 
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lanes 1 and 2 disappears after the DNase I treatment. Lane 4 had only 
DNase I added and again demonstrates that helper, vector, and env were 
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Figure 21. Plots of the densitometric scans of time 
course pulse-labeling (see Fluorogram in Figure 10), (-x-) 
represents Pr95 and (-6-) represents Pr76. 
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Figure 22. Southern hybridization using 32P-labeled 
pSV.KX to detect any SV40, env or E . coli sequences that were 
resistant to DNase I after the lysates and culture fluid were 
digested with trypsin/deoxycholate. Lanes 1-4 demonstrate 
the DNA from SV.KX infected cells. Lane 1 was untreated, 
lane 2 had pUC19 DNA added, lane 3 had pUC19 DNA and DNase I 
added, lane 4 had DNase I only. Lanes 6-9 show DNA from un-
transfected cells. The order of processing was the same as 
lanes 1-4. Lane 10 was p~SV.GAG digested with Kpn I and Xba 
I. Lanes 11-14 are samples from ~SV.GAG cotransfected cells. 
Lane 11 untreated samples, lane 12, samples with pUC19 DNA 
added, lanes 13 and 14 had pUC19 + DNase I and DNase I added 
respectively. Lanes 15-18 are samples from SV.KX 
cotransfected cells. The order of processing for lanes 15-18 
was the same as before. Lane 19 were DNA markers. Lane 20 
was pSV.KX digested with Kpn I and Xba I. Lanes 21-28 are 
samples collected from the cell culture fluid. Lanes 21 and 
22 are from ~SV.GAG cotransfected cells. Lanes 23-24 are 
samples from uninfecteced cells lane 23 had pUC19 DNA added 
only were as lane 24 had both pUC19 and DNase I added. Lanes 
25 and 26 are from SV.KX infected cells and processed in the 
same order as lanes 23 and 24. Likewise, lanes 27 and 28 are 
from SV . KX cotransfected cells. 
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all resistant to DNase I. These results are consistant with the ob-
servation that the vector, SV.KX, and helper DNA are packaged into in-
fectious SV40 particles as assessed by antigen and DNA detection in 
infected monolayers. Lanes 6-9 were samples from uninfected CV-1 
cells processed and run on the gel in the same order as before. Thus, 
the major band in lane 7 is linear plasmid DNA. Lane 10 contained 
p~SV.GAG DNA digested with Cla I and Xba I to release the vector, 
plasmid, and gag sequences from one another. The figure shows the 
pJC-2 sequences (3484 bp) and the SV40-vector sequences (3017 bp). 
The gag fragments were present on the ethidium-bromide stained gel but 
not seen on this autoradiogram because of the probe used. The upper 
bands are residual open circular· DNA resulting from incomplete 
restriction enzyme digestion. Lanes 11 through 14 show extracts of~ 
SV.GAG cotransfected cells at 89 hr. Lane 11, samples which did not 
receive DNase I or plasmid DNA, show both the helper DNA. and the SV40 
vector sequence of ~SV.GAG. The ratio of vector to helper that was 
originally used for the transfections (3:1) was observed on the den-
sitometric scan. The vector sequence disappears after the DNase I 
treatment (lanes 13 and 14) where as the helper DNA remains DNase I 
resistant. These results suggest that ~SV.GAG DNA was not packaged 
into virions. This is consistant with the observations that 6SV.GAG 
could not be passaged onto fresh monolayers. Lanes 15-18 are extracts 
from SV.KX cotransfected cells at 89 hr. The order of processing was 
the same as above. The extracts from the cotransfected cells look the 
same as the extracts from the SV.KX infected cells. Briefly, all the 
expected DNase I resistant DNA molecules (helper, vector, and env) are 
present after the DNase I treatment. These results futher strengthen 
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the results from lanes 1 through 4 in which the SV.KX vector is 
packaged into SV40 virions. Lane 20 was pSV.KX plasmid DNA digested 
with Kpn I and Xba I and included on the gel as a positive hybridiza-
tion control. Three major bands are seen corresponding to the plasmid 
(upper band of the doublet), vector (lower band of the doublet) and 
env (lower band) sequences. As in lane 10, the minor bands represent 
partially digested plasmid DNA. 
It indeed the vector~SV.GAG failed to be packaged into DNase I 
resistant virions, then the vector DNA should not be detected in the 
cell culture fluids whereas the helper DNA should. The remaining 
lanes (21 through 28) show DNAs purified from the pellet obtained from 
the cell culture fluids. Lanes 21 and 22 show DNA purified from the 
pellet produced from aSV.GAG c.otransfected monolayers. The sample in 
lane 22 was digested with DNase I whereas lane 21 was not. Inadver-
tently, plasmid DNA was omitted from both samples. As shown by the 
autoradiogram, only 'the helper DNA was present in the trypsin resis-
tant particles isolated from these culture fluids again.demonstrating 
that bSV.GAG was not packaged into SV40 virions. Longer exposures of 
the autoradiogram failed to show any vector sequences (data not 
shown). Lanes 23 and 24 are uninfected controls. Both samples 
received plasmid DNA but only the sample in lane 24 was digested with 
DNase I. The upper band in lane 23 probably consists of open circular 
plasmid molecules. Lanes 25 and 26 contain extracts purified from 
trypsin resistant particles produced in the SV.KX infected cells. 
Lane 27 and 28 contain DNAs purified from the medium of SV.KX 
cotransfected monolayers. All four of these lanes received plasmid 
DNA whereas only lanes 26 and 28 were digested with DNase I prior to 
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viral DNA extraction. All four lanes reveal helper, vector and env 
sequences to be present. Lanes 26 and 28 demonstrate that all of 
these sequences are resistant to DNAse (prior to the proteinase K di-
gestion) but the plasmid DNA was sensitive. It can be included from 
all the results described that the block to ASV.GAG propagation is due 
to an inability to package the vector DNA into SV40 virions. 
Localization of the Cis-Acting Sequence 
Interfering With SV.GAG Encapsidation 
In an attempt to localize the cis-acting element which inter-
feres with the encapsidation of ~SV.GAG DNA, many deletion mutants 
were made. Figure 23 shows a summary of these deletions and the ef-
fect they had on the propagation of their respective vectors. As 
shown in the table, the deletions span the entire length of the gag 
coding region. Three of these mutants also contain deletions which 
extend into the 5' proximal SV40 sequence. Two of these, named uSph 
I-Sph I 0.5 andaSphi-Sph I 1.5, were constructed by Eric Howard and 
were included in to table for completeness of the deletion analysis. 
The 0.5 and 1.5 indicate the number of SV40 enhancers deleted from 
each vector. The actual construction however will not be discussed 
but the effect they have on the propagation of the vector will be dis-
cussed later. Likewise, the propagation of SV.envDE and SV.envCE 
which were constructed by Lynette Bangs and Sue Denman will be ad 
dressed later. 
All of the constructions in this figurure have been previously 
described in this text except the Xho-Sph I deletion mutant. The 
original deletion of the Xho I-Sph I fragment from the gag coding 
110 
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Figure 23. Summary of the different deletion mutants con-
structed and their effects on the propagation of the respective vec-
tors. Replication was assayed by detection of vector and helper DNA 
in Hirt extracts of the cotransfected monolayers by ethidium bromide-
agarose gel electrophoresis as previously described. 
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region was made by Arrigo et al. (1987). This deletion mutation was 
introduced into the~SV.GAG genome by replacing the Sac II fragment of 
ASV.GAG with the Sac II fragment, containing the deletion mutation, 
from the proviral clone of Pr-CRSV. This clone was generously 
provided by Dr. K. Beeman (Johns Hopkins University, Baltimore, Ma.). 
Again this vector was unable to be propagated in CV-1 cells upon 
cotransfected (data not shown). 
The vector, SV.p27, was made by subcloning the p27 coding region 
of RSV (from the Rsa I to Bam HI sites) into the SV40 late region (see 
Materials and Methods). This vector was cotransfected into CV-1 cells 
and 5 days post transfection the monolayers were lysed and the SV40 
DNA was purified as described previously. Figure 24 shows that this 
vector was capable of replicating (lane 1). 
The results listed in Fig. 23 suggest that the inhibitory se-
quence is not located between the Sau 3a site in pl9 and the Bam HI in 
pl2 since these fragments alone did not inhibit propagation of the 
respective vectors. The other mutations listed which were constructed 
by deleting the remaining sequences of 6SV.GAG. These deletions 
failed to demonstrate the location of the inhibitory sequences since 






Figure 24. Samples of Hirt extracts from CV-1 cells 
cotransfected with helper and SV.p27 (lane 1), ASV.GAG (lane 
2), or SV.KX (lane 4). Samples from untransfected cells are 
shown in lane 3. "H" represents helper DNA and "V" repre-




Part I initially described the phenomenon of the inability to 
propagate the vector ~SV.GAG. It was further demonstrated in Chapter 
IV that this inability to propagate the vector was not due to a size 
packaging limitation or some other detrimental effect(s) imposed on 
the system by polypeptides synthesized by the vector. This phenomenon 
was examined in detail in hopes of understanding how some cis-acting 
element could inhibit the normal replicative strategy of simian virus 
40 and was reported in Chapter VI. 
Elucidating the Cause of the 
Block of ~SV.GAG Propagation 
It was demonstrated in Figure 15 that neither ~SV.GAG nor helper 
DNA could be detected in Hirt extracts from monolayers cotransfected 
with the DNAs at any time post-transfection when assayed by ethidium 
bromide-agarose gel electrophoresis. This phenomenon was also ob-
served with the 3' end deletion mutants and those mutants defective 
for Pr76 expression. These results are in contrast to those observed 
from extracts from both SV.KX-helper infected and cotransfected 
monolayers in which both the helper and the SV.KX DNAs were detected 
after 28 hr and 62 hr respectively. 
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To determine whether or not the possible cis-acting element in 
the ~SV.GAG vector was interfering with or altering the regulation of 
TAg expression via the early promoter, the vector was cotransfected 
into an SV40 permissive cell line, COS-1, which is constitutive for T 
Ag expression. Hirt extracts from these cotransfected COS-1 cells 
revealed that only the helper DNA was capable of being propagated. 
However, the possibility remains that the DNA observed in these ex-
tracts in not helper DNA but wild-type SV40 DNA arising from 
homologous recombination between the helper and vector genomes. It 
seems unlikely though that such an event would occur at a frequency 
high enough to allow wild-type SV40 DNA to replicate and sub~equently 
be detected by 90 hr. 
These results suggest, although indirectly, that the regulation 
of SV40 gene expression is not altered in the ASV.GAG vector. So to 
further define the different stages of the SV40 replicative cycle, the 
timing of the first round of DNA replication and late gene expression 
for both the SV.KX and ASV.GAG expression vectors was determined. 
Vector DNA Replication 
and Late Gene Expression 
Since it has already been shown that the vector, ASV.GAG, was 
not proficient at producing infectious progeny virus, it was of inter-
est to determine whether or not the vector was even capable of 
replicating in the transfected cells. Since only a few cells are com-
petent to take in exogenous DNA, DNA replication could only be 
detected by Southern hybridizations. 
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Figure 17 demonstrated that both vectors, /:;>.SV.GAG and SV.KX, 
were capable of DNA replication in the cotransfected monolayers and 
both had similar replication times. The time of replication is con-
sistent with that seen in SV.KX infected COS-1 cells as well as that 
reported by Schirmbeck and Deppert (1987). It was also shown in 
Figure 19 that neither the vector nor helper DNAs had a selective ad-
vantage of being replicated since the ratio of vector to helper (3:1) 
was maintained after DNA replication. 
SV40 late gene expression was also determined for both vectors 
by both time course intracellular immunofluorescence and im-
munoprecipitations using antiviral antibodies specific for the dif-
ferent antigens. Both experiments demonstrated that late gene expres-
sion beings prior to 36 hr but after 23 hr post-transfection. This 
result is consistent with the regulation of SV40 since the late phase 
of the viral replication cycle is marked by the onset of viral DNA 
replication. 
Since correct DNA replication and late gene expression have been 
confirmed, the ability of the ASV.GAG DNA to become DNase I resistant 
by being packaged into particles was tested. The results in Figure 22 
imply that both the helper and SV.KX vector DNAs, both in the cell 
lysate and released into the culture fluid, are resistant to DNase I. 
Only the helper DNA, on the other hand, remains DNase I resistant in 
the ASV.GAG-helper cotransfected cells. It was also shown in this 
figure that only the helper DNA was released from the cells into par-
ticles that could be collected by centrifugation. The centrifugal 
force at which these "particles" were collected is the same force re-
quired to pellet SV40 virus particles. The fact that only the helper 
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virus was capable of being packaged in SV40 particles is consistent 
with the results described earlier in which only the helper virus was 
capable of replicating in COS-1 cells. These observations, along with 
the following proposed requirement of SV40 chromatin structure for 
SV40 DNA encapsidation, raises some very interesting questions regard-
ing the chromatin structure of the A SV. GAG "minichromosome." 
All eukaryotic organisms have approximately 99% of their genome 
highly condensed by histone proteins into transcriptionally inert 
heterochromatin (Steitz, 1987). Active chromatin (euchromatin) on the 
other hand is generally found in more open or DNase I hypersensitive 
regions (Weintraub, 1985; Ryoji and Worcel, 1984; and Rose and Gar-
rrard, 1984). It has been established ~hat these hypersensitive sites 
often reside within cis-acting regions of transcriptionally active 
chromatin (Cockerill and Garrard, 1986; and Igo-Kemenes et al., 1982). 
It has also been suggested that some of these hypersensitive sites 
might arise from trans-acting factors recognizing enhancer elements in 
transcriptionally poised regions (Weintraub. 1985; and Wang and 
Calame, 1986). Other hypersensitive regions of the chromosome pos-
sibly represent promoter regions where RNA Polymerase can gain entry 
into the double helix and DNA origins of replication where the DNA 
replication machinery can gain access (Gross and Garrad, 1987). The 
SV40 genome is no exception. 
The SV40 chromosome seems to always be packaged into 20 to 24 
nucleosomes with a nucleosome periodicity of approximately 198 bp 
(Shelton et al., 1980). Even though it is not clear what the struc-
ture of the transcriptionally poised nucleosome is, it is known that 
transriptionally active genes can be associated with nucleosomes 
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(Igo-Kemenes et al., 1982). These nucleosomes however are not evenly 
spaced about the viral chromosome (Scott and Wigmore, 1978). There is 
a major DNase I hypersensitive region located around the SV40 origin 
of replication. This region not only contains the SV40 ori but also 
contains both the early and late promoters as well as the two 72 bp 
repeats (also known as the SV40 enhancer elements) (Saragosti et al., 
1982). Blasquez et al. (1986) suggest that during SV40 replication 
but prior to viral assembly, the 24 nucleosomes are placed nonrandomly 
on the SV40 DNA so that the hypersensitive region is exposed to 
trans-acting factors like DNA polymerase and the T Ag. After late 
gene expression, viral capsid proteins may redirect nucleosomes toward 
the "open" region thereby increasing the nucleosome periodicity to 211 
bp. This periodicity they suggest is a prerequisite for SV40 packag-
ing. They also presented evidence that a temperature-sensitive SV40 
late protein, VPl, wa~ incapable of directing the change in nucleosome 
periodicity at the nonpermissive-temperature and this ts mutant was 
incapable of virion assembly. This ts mutant was however capable of 
directing the nucleosome rearrangement and and packaging its DNA into 
virus particles at permissive temperatures (Blasquez et al., 1983). 
Given the data presented in Chapters IV and VI along with the 
observations of Blasquez et al (1983 and 1986), I propose that 6SV. GAG 
contains some cis-acting element(s), with or without trans-acting 
factor(s), which may alter the nucleosome spacing or rearrangement 
such that correct nucleosome periodicity, required for packaging, is 
not achieved. Such elements might include the directional enhancer 
described by Arrigo et al. (1987) or some other unidentified 
element(s) located in the gag coding region. 
Localization of the Responsible 
Cis-acting Sequence 
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In attempts to localize the cis-acting sequence in the gag 
coding region responsible for inhibiting the encapsidation of the vec-
tor, a series of different deletion mutations spanning the entire 
length of the gag coding region was made (see Figure 23). The pos-
sibility that Pr76 or some other product initiating translation at the 
5' end of the gag coding region was eliminated by the creation of the 
+1 frameshift mutant (at the unique Xho I site) and the Kpn I-Xho I 
deletion mutant. These two mutations along with the fact that only 
the vector and not the helper DNA was inhibited from being packaged 
established that a cis-acting element unique to the gag coding region 
was probably responsible for inhibiting the production of ASV.GAG 
virions. We have not ruled out though the possibility that an RNA 
molecule might be exerting some effect(s) on the SV40 replication 
cycle. This possibility though seems unlikely since the RNA would 
have to act in cis or selectively act in trans. 
The results presented in figure 23 suggest that the elements(s) 
in the gag coding region which are responsible for the block to virion 
production are not located between the Sau 3a site in the pl9 coding 
region and the Bam HI site in the pl2 coding region. 
It has also been shown that the responsible sequence is not lo-
cated 3' of the p27 coding domain since the Bal 31 deletion mutants 
were also unstable (see Part I, Chapter V). The only sequences 
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remaining are those 5' of the Sau 3a site. However, when these se-
quences were removed form the ASV.GAG vector, they did not alleviate 
the block to virion production. 
Of all the ASV.GAG deletion mutants made, only two were stably 
maintained in CV-1 monolayers. Interestingly these two deletion 
mutants (~Sph I-Sph I 0.5 and ASph I-Sph I 1.5) were either missing 
1/2 or 1 1/2 of the SV40 enhancer elements. As shown in Figure 23, 
removal of the SV40 cis-acting elements alleviated the block in 
propagation of theASV.GAG vector. 
This is not too surprising since its known that enhancer ele-
ments can alter the nucleosome periodicity leading to the creation of 
DNase I hypersensitive sites (Weintraub, 1985 and Wang and Calame. 
1986). Removal of these elements might have allowed random nucleosome 
positioning in the DNase I hypersensitive region of the SV40 mini-
chromosome regardless of any inhibitory elements located in the gag 
gene and thus allow encapsidation of the vector genomes. 
Even though every sequence in the Pr76 coding domain of the 
vector, ASV.GAG, has been systematically omitted, localizing a cis-
acting element which interfered with the packaging of the vector DNA 
into virus particles failed. This does not mean however that such an 
element does not exists. It may be that the element along with other 
flanking or nonflanking sequences work in tandem to inhibit genome 
packaging, possibly by interfering with nucleosome rearrangements. 
The possibility that some host factor(s) may preferentially bind to 
the gag sequences thus altering a required DNA packaging structure has 
not been eliminated. All of the results presented in Part I and Part 
II strongly suggest that there are probably more than one element 
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residing in the gag gene which inhibit encapsidation of the vector 
genome. These elements which seem. to exert a negative effect on the 
normal process of SV40 packaging may be very important in regulating 
retroviral gene expression in the avian system by possibly altering 
nucleosome periodicity thus creating a DNase I hypersensitive domain 
at the site of provirus integration. 
tive. 
This however is purely specula-
The work presented in Part I suggests that the block to Rous 
sarcoma virus replication in mammalian cells lies solely at the 
transcriptional or translational level· and not at the level of precur-
sor processing. ·The work presented in Part II possibly suggests that 
important sequences which govern RSV expression, other than the LTRs, 
may lie in the Pr76 coding domain and possibly influence expression by 
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Adjust pH to 7.5.with 5N NaOH 
Ampicillin 
Disslolve 25 mg per milliliter of water. 





Prepare stock solution at 34 mg/ml in 100% ethanol 
Penicillin-Streptomycin 
Per 100 ml; 
Penicillin G 
Streptomycin 
Use 0.5 ml pe.r 500 ml of medium 












trizma base 6.0g 
H20 750ml 
pH to 7.2 with HCl and filter sterilize 





MgCl2 -6H20 250ul 2 M MgC12 stock 
NaCl 8.0g 
Na2HP04 (anhydrous) 1.14g 
H20 750ml 




trizma base 1.2lg 
Na2EDTA 0.42g 
Penicillin G 0.067g 
Streptomycin 0.057g 
H20 750ml 
pH to 7.2 with HCl and filter sterilize 
Concentrated Trypsin (0.25%) 
Per 500 ml; 
Trypsin 1.25g 
TBS 50ml 
Stir overnight at 4°C 
Pellet particulate matter by centrifugation at 
9,000 x g in a type SS35 rotor. 
Pour supernatant into 450 ml sterile TBS 
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APPENDIX B 
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) 
SOLUTION 




H20 to make 1 liter. 




Stock B. 2.0 M Tris-Cl. pH 8.8 (Resolving Gel Buffer) 
Per liter; 
tris base 
Adjust pH to 8.8 with HCL 
Add H20 to 1 liter 
484.6 g 
Stock C. 0.5 M Tris-Cl. pH 6.8 (Stacking Gel Buffer) 
Per liter; 
tris base 60.6 g 
Adjust pH to 6. 8 with HCl 
Add H20 to 1 liter 
Stock D. Electrophoresis Buffer (lOx) 
Per liter; 
tris base 30.34 g 










Dissociation Buffer (lx) 
Per 20 ml; 













Preparation of Resolving Gel (10% acrylamide) 
Per 30 ml (1 gel); 
Acrylamide:BIS (30:0.8) 10 ml 
2 M tris-Cl pH. 8.8 6 ml 
H20 13.7 ml 
10% SDS 0.3 ml 
10% ammunium persulfate 0.3 ml 
TEMED 0.020 
Preparation of Stacking Gel (3% acrylamide) 
Per 15 ml (for 1-2 gels); 
Acrylamide:BIS (30:0.8) 1.5 ml 
0.5 M tris-Cl pH. 6.8 1.8 ml 
H20 11.5 ml 
10% SDS 0.150 












Coomassie Blue Stain for Protein Gels 
Per 500 ml; 
Coomassie Blue R250 
95% ethanol 
Glacial acetic acid 
H20 
Destain for Protein Gels 
Per 500 ml; 
Methanol 
Glacial acetic acid 














AGAROSE GEL ELECTROPHORESIS 
Tris-acetate Buffer (SOx) 
Per 500 ml; [Final lx] 
trizma base 2.5 g 
0.04 M tris-acetate 
Glacial acetic acid 29 ml 
0.5 M EDTA, pH. 8.0 50 ml 1 mM EDTA, pH. 8.0 
Sample Dye 
Per 10 ml; 
Ficoll 2.5 g 
10% Bromphenol Blue R250 1.0 ml 
Make up in TE Buffer 
(10 mM tris-Cl, pH. 8.0, 1 mM EDTA, pH. 8.0) 
APPENDIX D 
SOUTHERN HYBRIDIZATION SOLUTIONS AND BUFFERS 
20x SSC Buffer 
Per liter; 
NaCl 173.9 g 
NaCitrate 88.2 g 
H20 800 ml 
Adjust pH. to 7.0 with HCl and add H20 to one liter 
Sterilize by autoclaving, store at room temperature 




0.5 M NaOH. 1.0 M NaCl 
Per liter; 
5 M NaOH 
NaCL 














Per 20 ml; 
20x sse buffer s ml 
10% SDS 1 ml 
SOx Denhart's solution 2 ml 
O.S M EDTA, pH. 8.0 40 ul 
10 mg/ml Salmon Sperm DNA 200 ul 
(denatured) 
deionized formamide 9 ml 
H20 2.79 ml 
SOx Denhart's Solution 
Per soo ml; 
Ficol s g 
Polyvinylpyrrolidine s g 
Bovine serum albumin (BSA) s g 
(Pentax fraction V) 
Sterilize by filtration and store at -20°C 
lOx Nick Translation Buffer 
Per 1 ml; 
1 M tris-Cl SOO ul O.S M 
2 M MgS04 SO ul 0.1 M 
O.S M dithiothreitol 2 ul lmM 
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